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Polyhydroxybutyrate (PHB) is a polyhydroxyalkanoate that has been extensively 
studied as a potential biodegradable replacement for petrochemically derived plastics. 
The synthesis pathway of PHB is native to Ralstonia eutropha, but the genes for the PHB 
pathway have successfully been introduced into Escherichia coli through plasmids such 
as the pBHR68 plasmid. However, the production of PHB needs to be more cost-
effective before it can be commercially produced. 
A mathematical model for PHB synthesis was developed to identify target genes 
that could be genetically engineered to increase PHB production. The major metabolic 
pathways included in the model were glycolysis, acetyl coenzyme A (acetyl-CoA) 
synthesis, tricarboxylic acid (TCA) cycle, glyoxylate bypass, and PHB synthesis. Each 
reaction in the selected metabolic pathways was modeled using the kinetic mechanism 
identified for the associated enzyme. The promoters and transcription factors for each 
enzyme were incorporated into the model. The model was validated through comparison 
with other published models and experimental PHB production data.   
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The predictive model identified 16 enzymes as having no effect on PHB 
production, 5 enzymes with a slight effect on PHB production, and 9 enzymes with large 
effects on PHB production. Decreasing the substrate affinity of the enzyme citrate 
synthase resulted in the largest increase in PHB synthesis. The second largest increase 
was observed from lowering the substrate affinity of glyceraldehyde-3-phosphate 
dehydrogenase. The predictive model also indicated that increasing the activity of the lac 
promoter in the pBHR68 plasmid resulted in the largest increase in the rate of PHB 
production. 
The predictive model successfully identified two genes and one promoter as 
targets for genetic engineering to create an optimized strain of E. coli for PHB 
production. The substrate-binding sites for the genes gltA (citrate synthase) and gapA 
(glyceraldehyde-3-phosphate dehydrogenase) should be genetically engineered to be less 
effective at binding the substrates. The lac promoter in the pBHR68 plasmid should be 
genetically engineered to more closely match the consensus sequence for binding to RNA 
polymerase. The model predicts that an optimized strain of E. coli for PHB production 
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 Plastics are a versatile and widely used material. However, traditional plastics are 
derived from petrochemicals and are not biodegradable. Polymers synthesized from 
microorganisms that have similar properties to plastic are potential biodegradable 
replacements. The objective of this project is to use mathematical modeling as a tool to 
engineer a strain of bacteria optimized for the production of bio-plastics. 
 Production costs can be reduced by using a bacterial strain specifically optimized 
for bio-plastic production. By reducing production costs, bio-plastics will be able to 
commercially compete with traditional plastics. Society will benefit as bio-plastics 
replace traditional plastics. Fossil fuels will not be depleted by the production of 
traditional plastics, and the bio-plastics will biodegrade in landfills. 
 The costs of this research are nominal. Developing a model takes only time and 
minimal laboratory work. An effective predictive model will reduce laboratory time and 
cost because it will indicate how to efficiently engineer a microorganism strain optimized 
for the production of bio-plastics. This design process can also be used to develop 
predictive models for the production of other bioproducts such as biofuels, biomaterials, 
and biopharmaceuticals. 
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Need for Study 
Plastic is one of the most heavily used compounds in the United States. 
Traditional plastics are versatile in use and have low production costs. However, they are 
produced from non-renewable petrochemicals that are not biodegradable (Reddy et al, 
2003). A sustainable alternative is needed in order to decrease both the use of non-
renewable fossil fuels and the buildup of plastic in landfills (Reddy et al, 2003). 
Polyhydroxybutyrate (PHB) is a polyhydroxyalkanoate that has been extensively 
studied as a potential biodegradable replacement for petrochemical plastics (Byrom, 
1987). Polyhydroxyalkanoates are storage material for many gram-positive and gram-
negative bacteria (Choi & Lee, 1999). The bio-plastic is created and stored intracellularly 
as a reserve of carbon, energy, and reducing power during periods of stress or nutrient 
limitation (Doi, 1990; Lee, 1996; Madison & Huisman, 1999). The polymerization of the 
soluble nutrients into insoluble compounds prevents leakage out of the cell. This process 
allows the bacteria to have continued access to nutrients at a low maintenance cost.  
Many bacteria, such as Zoogloea ramigera (Madison & Huisman, 1999; Ploux et 
al, 1988) and Ralstonia eutropha (Haywood et al, 1988; Haywood et al, 1989; Madison 
& Huisman, 1999; Slater et al, 1998; Steinbüchel & Schlegel, 1991), are capable of 
producing and degrading PHB and other polyhydroxyalkanoates. Genes for PHB 
synthesis can be cloned into other bacteria such as Escherichia coli. One of the 
advantages of using E. coli for the production of PHB is because E. coli is unable to 
degrade PHB into soluble compounds (Madison & Huisman, 1999). 
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The production of PHB, or any polyhydroxyalkanoate, is costly due to its carbon 
source and downstream processing costs (Gurieff & Lant, 2007). The high cost of $2.65-
5/kg is the main reason for the limited application of these bio-plastics (Choi & Lee, 
1997; Choi & Lee, 1999). Further studies are needed to help make PHB production more 
cost-effective before it can be commercially produced. 
Metabolic modeling is a tool that has been used to determine rate-limiting steps 
and conditions of PHB production. However, metabolic models have focused solely on 
the three enzymes in the PHB synthesis pathway and have neglected to account for other 
key pathways in the cell (Leaf & Srienc, 1998; Van Wegen et al, 1998; Van Wegen et al, 
2001). Models have also failed to account for the transcriptional network that is essential 
in understanding how enzymes of interest are regulated. Most models focus on 
optimizing the culturing methods to improve PHB production, but seldom address the 
possibility of optimizing the prokaryotic strain (Choi & Lee, 1997; Choi & Lee, 1999; 
Jurasek & Marchessault, 2004; Leaf & Srienc, 1998; Mantzaris et al, 2002; Shang et al, 
2007; Van Wegen et al, 1998; Van Wegen et al, 2001). 
A predictive model of the metabolic pathways of the cell should be able to 
quantitatively predict how changes in one pathway can affect the synthesis rate of a 
product of interest. This approach would require the predictive model to account for the 
complex metabolic pathways present in a cell. A model that focuses on one metabolic 
pathway lacks valuable information on what is happening elsewhere in the cell. A more 
complex model that accounts for many metabolic pathways and their transcriptional 
networks could be used as a guide in the laboratory for engineering optimized 
prokaryotic factories. Utilizing the synthetic biology toolbox, a strain of E. coli with its 
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metabolic pathways optimized for the synthesis of a single product could be engineered. 
The predictive model will allow one to target specific enzymes, promoters, or 
transcription factors out of many metabolic pathways for genetic engineering. 
A model encompassing the major metabolic pathways associated with PHB 
synthesis will help determine the amount of energy and reducing power that can be 
diverted into the PHB synthesis pathway for the optimal PHB production. The major 
pathways involved in PHB synthesis that are included in the model are glycolysis, acetyl 
coenzyme A (acetyl-CoA) synthesis, tricarboxylic acid cycle (TCA), glyoxylate shunt, 
and PHB synthesis (Madison & Huisman, 1999). The model must effectively simulate the 
individual reactions in the previously mentioned pathways. Kinetic mechanisms, kinetic 
parameters, genes, and transcription factors must be determined for each reaction. Events 
and rules can simulate conditions that trigger the regulation of each enzyme to simulate in 
vivo conditions. 
Flux balance analysis (FBA) is a tool currently used to model genome-scale 
metabolic networks. FBA is a constraint approach that focuses on stoichiometric 
information rather than kinetic data. Stoichiometric data is more widely available than 
kinetic data for different reactions and organisms. However, the kinetic data needed to 
build a genome-scale mechanistic model will become available as technology advances 
the collection of high throughput metabolomic data (Jamshidi & Palsson, 2008). Models 
based on FBA can be used to predict outcomes of gene deletion or addition, but not gene 
modification (Feist et al, 2009; Oberhardt et al, 2009; Orth et al, 2010; Price et al, 2003; 
Raman & Chandra, 2009; Schellenberger et al, 2011). A mechanistic model based on 
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kinetics could be used to predict how to genetically modify an existing enzyme to 
increase production of a specific bioproduct.  
A constraint based approach such as FBA results in a static model whereas a 
kinetic based approach produces a dynamic model. As a static model, FBA also does not 
account for the transcriptional network that regulates enzyme expression. Attempts have 
been made to incorporate a regulatory network into FBA through the use of Boolean 
logic operators (Orth et al, 2010; Price et al, 2003; Raman & Chandra, 2009). However, a 
binary system based on Boolean logic operators fails to account for the entire dynamic 
range of the regulatory system.  
Metabolic profiling is a tool capable of providing the details needed for a 
predictive mechanistic model. Metabolic profiling is a quantitative analysis of specific 
metabolites over time. The general protocol for metabolic profiling is to take samples 
from a culture and quench the metabolic activity. The two most common quenching 
methods are freezing the samples with liquid nitrogen, or shocking with a cold-buffered 
aqueous methanol mixture (Bajad et al, 2006; Buchholz et al, 2001; Dettmer et al, 2006;  
Lu et al, 2008; Mashego et al, 2007; Ohashi et al, 2007). 
Once samples have been prepared, specific metabolites can be analyzed through 
combinations of liquid chromatography (LC), gas chromatography (GC), mass 
spectrometry (MS), capillary electrophoresis (CE), and nuclear magnetic resonance 
(NMR) (Bajad et al, 2006; Buchholz et al, 2001; Dettmer et al, 2006; Lu et al, 2008; 
Mashego et al, 2007; Ohashi et al, 2007). Liquid chromatography coupled with mass 
spectrometry (LC-MS) is a powerful tool because it is capable of analyzing many 
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metabolites simultaneously using a small sample volume. One study successfully 
analyzed as many as 69 metabolites simultaneously (Bajad et al, 2006).   
LC-MS analysis can provide concentrations of metabolites at specific times in the 
culture when compared to standard curves. These values can then be incorporated into the 
predictive model so that the model more accurately represents the specific prokaryotic 
strain under analysis. The predictive model can then be optimized for PHB production 
and can identify the target genes for genetic engineering. After the prokaryotic strain has 
been genetically engineered, another round of metabolic profiling can be conducted to 
determine how the new strain performs compared to the optimized model. 
 
Objectives 
The objective of this project was to develop a mathematical model for PHB 
synthesis in E. coli for the identification of key regulators and optimal conditions for 
PHB synthesis. To achieve this objective, the model included pathways for glycolysis, 
acetyl-CoA synthesis, TCA cycle, the glyoxylate pathway, and PHB synthesis. The 
model incorporated enzymes, cofactors, and transcription factors for each reaction in the 
pathways. The model was fitted to published models and to real-time data in order to 
increase its accuracy. Metabolic profiling was employed to collect real-time data utilizing 
LC-MS for metabolite identification and quantification. Sensitivity analysis was used on 
the model to identify the key regulators and optimal conditions for the best PHB 
production. The goal of this project was to provide direction for how to genetically 
engineer E. coli to achieve higher production rates of PHB. 
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PATHWAYS AND REACTIONS 
Metabolic pathways are composed of biochemical reactions that allow organisms 
to both degrade and construct compounds like PHB. Five metabolic pathways were 
selected to be incorporated into this mathematical model based on criteria that include 
energy, reducing power, and common substrates with the PHB synthesis pathway. The 
five metabolic pathways were PHB synthesis, TCA cycle, glyoxylate pathway, 
glycolysis, and acetyl-CoA synthesis. 
Each pathway is a set of reactions that was modeled based on each reaction’s 
kinetic mechanism. The kinetic mechanism and parameters are dependent upon the 
enzyme that catalyzes each reaction. Studies on these enzymes have revealed many of 
their kinetic mechanisms and parameters. This chapter explains the justifications behind 
every equation and parameter used to model each reaction. 
 
PHB Synthesis 
The PHB synthesis pathway is composed of three biochemical reactions that 
convert acetyl-CoA into PHB. This pathway contains two intermediates: acetoacetyl-CoA 
and 3-hydroxybutyryl-CoA. The cofactors CoA and NADPH/NADP
+
 contribute to these 
reactions. The enzymes β-ketothiolase (PhaA), acetoacetyl-CoA reductase (PhaB), and 
poly-β-hydroxybutyrate polymerase (PhaC) each catalyze one of the three reactions 
shown in Figure 1. 
 




Figure 1. The metabolic pathway for the synthesis of PHB. 
 
Reaction 1: 
             
              
↔                               
 
Enzyme: β-ketothiolase 
The first step in PHB synthesis is catalyzed by the enzyme β-ketothiolase, also 
known as acetyl-CoA acetyltransferase. The enzyme β-ketothiolase condenses two 
acetyl-CoA molecules into one acetoacetyl-CoA in the forward reaction. The reversible 
reaction is known as the thiolysis reaction. In many organisms, such as Ralstonia 
eutropha (also previously known as Alcaligenes eutrophus and Cupriavidus necator), 
there are two β-ketothiolases able to synthesize PHB. Enzyme A can utilize the substrates 
acetoacetyl-CoA and 3-ketopentanoyl-CoA. Enzyme B can cleave a wider variety of 
substrates that include: acetoacetyl-CoA, 3-ketoheptanoyl-CoA, 3-ketopentanoyl-CoA, 3-
ketohexanoyl-CoA, 3-ketooctanoyl-CoA, and 3-ketodecanoyl-CoA. Studies have shown 
that enzyme B is the primary β-ketothiolase utilized in PHB synthesis (Madison & 
Huisman, 1999; Slater et al, 1998). 
 





The enzyme β-ketothiolase exhibits normal Michaelis-Menten kinetics in the 
absence of CoA (Oeding & Schlegel, 1973; Senior & Dawes, 1973). In multiple 
organisms, the enzyme displayed competitive-inhibition in the presence of CoA 
(Haywood et al, 1988; Mothes et al, 1997; Oeding & Schlegel, 1973; Steinbüchel & 
Schlegel, 1991). Based on the non-linear Lineweaver-Burk plots in the presence of CoA, 
Oeding and Schlegel proposed a ping-pong mechanism with CoA as the binary term. Hill 
kinetics were observed with coefficients of n = 1 in the absence of CoA and n = 2 in the 
presence of CoA (Oeding & Schlegel, 1973). 
Based on the findings described above, it was decided to use Equation (1) for the 
condensation reaction. Equation (1) combines the kinetics of competitive-inhibition with 
Hill cooperativity. Acetyl-CoA was used as the substrate, S, and CoA was used as the 
inhibitor, I. The kinetic parameters utilized in simulations of this model are shown in 
Table I. No kinetic data were available on E. coli for β-ketothiolase. Because the genes 
for β-ketothiolase in E. coli come from R. eutropha, when available, it was preferable to 
use kinetic data from R. eutropha (or A. eutrophus, C. necator) rather than from other 
organisms. Because the enzyme B of β-ketothiolase is preferred over the enzyme A in 
PHB synthesis (Madison & Huisman, 1999; Slater et al, 1998), Km values for enzyme B 
were chosen over enzyme A in this model. No value in the literature was found for Vm in 
R. eutropha. All values found for Vm are shown in Table I.  
 
Reverse Reaction: 
In the direction of thiolysis, β-ketothiolase does not obey Michaelis-Menten 
kinetics. Studies indicate that there is a positive cooperativity between acetoacetyl-CoA 
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and CoA (Haywood et al, 1988; Steinbüchel & Schlegel, 1991). Lineweaver-Burk plots 
yield a family of parallel lines at varied concentrations of acetoacetyl-CoA or CoA. 
Parallel lines indicate that this reaction follows a ping-pong bi-bi mechanism (Molina et 
al, 1994; Oeding & Schlegel, 1973).  
For this model, it was decided to use Equation (2), the ping-pong bi-bi 
mechanism, for the thiolysis reaction. Acetoacetyl-CoA was used as substrate A, and 
CoA was used as substrate B. Kinetic parameters utilized in simulations of this model are 
































    (1) 
   
 VMAX  =  kcat*[E] = [µM/s] 
 KM =  Substrate concentration resulting in 0.5VMAX = [µM] 
 Ki = Inhibitor concentration in 0.5VMAX = [µM] 
 kcat  =  Maximum number of rxns catalyzed per second = [s
-
] 
 [S]  =  Concentration of substrate = [µM] 
 [E] =  Concentration of enzyme = [µM] 
 [I] = Concentration of inhibitor = [µM] 






















                                        (2) 
   
 VMAX  =  kcat*[E] = [µM/s] 
 KA = Dissociation constant for substrate A = [µM] 
 KB =  Dissociation constant for substrate B = [µM] 
 kcat  =  Maximum number of rxns catalyzed per second = [s
-
]  
 [A]  =  Concentration of substrate A = [µM] 
 [B] =  Concentration of substrate B = [µM] 
 [E] =  Concentration of enzyme = [µM] 
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Table I. Kinetic parameters utilized for Reaction 1 in the model. 



















Steinbüchel & Schlegel, 1991 
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Senior & Dawes, 1973 
Berg et al, 2007 
Berg et al, 2007 
Alber et al, 2006 
Mothes et al, 1997 
Sliwkowski & Hartmanis, 1984 
Ki 16 µM A. eutrophus Steinbüchel & Schlegel, 1991 













Steinbüchel & Schlegel, 1991 











Steinbüchel & Schlegel, 1991 
Steinbüchel & Schlegel, 1991 
Vm 1.24 µM/s M. rhodesianum Mothes et al, 1997 
a. Enzyme A of β-ketothiolase 
b. Enzyme B of β-ketothiolase 
 
Reaction 2: 
                         
                         
↔                  
                           
 
 
Enzyme: Acetoacetyl-CoA reductase 
Acetoacetyl-CoA reductase catalyzes the second step in PHB synthesis by 
converting acetoacetyl-CoA into 3-hydroxybutyryl-CoA. It has been classified as a 
NADPH-dependent reductase. The availability of reducing power is one of the main 
driving forces for PHB synthesis. Thiolysis is the thermodynamically favored direction; 
however, under favorable PHB accumulating conditions, acetoacetyl-CoA reductase can 
pull the reaction in the condensation direction (Madison & Huisman, 1999). 




The kinetics of acetoacetyl-CoA reductase vary by organism. The enzyme has 
been shown to have cooperativity factors in M. extorquens for acetoacetyl-CoA and 
NADPH (Belova et al, 2006). However, it has been shown that there are no cooperativity 
factors in M. rhodesianum (Mothes & Babel, 1994). Kinetic behavior indicates inhibition 
with the substrate acetoacetyl-CoA at high concentrations in multiple organisms (Belova 
et al, 2006; Mothes & Babel, 1994; Ploux et al, 1988). Normal Michaelis-Menten 
kinetics have been observed in A. beijerinckii (Ritchie et al, 1971). Also, a sequential 
kinetic mechanism has been observed in Z. ramigera (Ploux et al, 1988). 
The literature contained Km values for acetoacetyl-CoA and NADPH/NADH 
(Steinbüchel & Schlegel, 1991) in A. eutrophus, but no mechanism was proposed. Due to 
the dependence on NADPH/NADH and the sequential kinetic mechanism observed in Z. 
ramigera, it was decided to use an ordered bi-bi mechanism, Equation (3), to model this 
reaction. Substrate A was acetoacetyl-CoA, and substrate B was NADPH/NADH. The 
NADPH dependent enzyme is the one used in PHB synthesis (Madison & Huisman, 
1999); therefore, kinetic parameters for the NADPH dependent enzyme shown in Table II 

























            (3) 
   
 VMAX  =  kcat*[E] = [µM/s] 
 KA = Dissociation constant for substrate A = [µM] 
 KB =  Dissociation constant for substrate B = [µM] 
 kcat  =  Maximum number of rxns catalyzed per second = [s
-
]  
 [A]  =  Concentration of substrate A = [µM] 
 [B] =  Concentration of substrate B = [µM] 
 [E] =  Concentration of enzyme = [µM] 





The literature contained no proposed kinetic mechanism for the thiolysis reaction 





 were found in A. eutrophus (Steinbüchel & Schlegel, 1991). It was 
decided to model this reaction with the same mechanism utilized in the condensation 
reaction. An ordered bi-bi mechanism, Equation (3), was employed with substrate A as β-





Although both NADPH and NADH dependent acetoacetyl-CoA reductase exist in 
A. eutrophus, only the NADPH dependent enzyme is used in PHB synthesis (Madison & 
Huisman, 1999). Therefore, kinetic parameters for the NADPH dependent enzyme were 
used in the model as shown in Table II. The parameter Vm was not found for the thiolysis 
reaction. The same value used in the condensation reaction was used in the thiolysis 
reaction model. 
 
Table II. Kinetic parameters utilized for Reaction 2 in the model. 











Steinbüchel & Schlegel, 1991 









Steinbüchel & Schlegel, 1991 
Steinbüchel & Schlegel, 1991 











Steinbüchel & Schlegel, 1991 









Steinbüchel & Schlegel, 1991 
Steinbüchel & Schlegel, 1991 
Vm 0.023 µM/s R. sphaeroides Alber et al, 2006 
a. NADPH dependent 
b. NADH dependent 
 




( )                     
              
→                                    ( )    
 
Enzyme: Poly-β-hydroxybutyrate polymerase (PHB synthase) 
  
The enzyme poly-β-hydroxybutyrate polymerase, also known as PHB synthase, 
catalyzes the third step in the PHB synthesis pathway. This enzyme exists in both soluble 
and granule-associated forms (Haywood et al, 1989; Madison & Huisman, 1999). In 
carbon-limited environments, most PHB synthase is soluble. In nitrogen-limited 
environments, the majority of PHB synthase is granule-associated (Haywood et al, 1989). 
PHB synthase can polymerize 3-hydroxybutyrate units to form poly-3-hydroxybutyrate 





Poly-β-hydroxybutyrate polymerase demonstrated normal Michaelis-Menten 
kinetics in A. eutrophus (Haywood et al, 1989). Equation (4) was used to model the 
forward reaction using kinetic parameters from Table III. The molecular weight of PHB 
assumed for this model was 160,000 Daltons because of its association with the kinetic 
parameters in Table III (Haywood et al, 1989). Using the molecular weight of 160 kDa 
results in a PHB polymer composed of 1,860 units of 3-hydroxybutyrate. The 
stoichiometric coefficient n in Reaction 3 was set as 1,860 in the model. Kinetic 
parameters for the granule-associated PHB synthase were used in the model due to the 
unstable nature of the soluble PHB synthase (Haywood et al, 1989). 





The reverse reaction was ignored in this model because E. coli do not naturally 
code for PHB depolymerase (Saito et al, 1989). The PHB depolymerase gene will not be 













                   (4) 
 
 
VMAX  =  kcat*[E] = [µM/s] 
 KM =  Substrate concentration resulting in 0.5VMAX = [µM] 
 kcat  =  Maximum number of rxns catalyzed per second = [s
-
] 
 [S]  =  Concentration of substrate = [µM] 
 [E] =  Concentration of enzyme = [µM] 
 
 
Table III. Kinetic parameters utilized for Reaction 3 in the model. 















Haywood et al, 1989 
Haywood et al, 1989 
Haywood et al, 1989 
Vm 0.0047 µM/s A. eutrophus Haywood et al, 1989 
a. (R)-3-hydroxybutyryl-CoA as substrate 
b. (R)-3-hydroxyvaleryl-CoA as substrate 
c. Granule associated synthase 




The tricarboxylic acid (TCA) cycle is composed of nine reactions that utilize 
acetyl-CoA to generate energy and reducing power. Nine enzymes catalyze the reactions 





/NADPH. The TCA cycle takes a portion of 
acetyl-CoA away from PHB synthesis. Cells need energy, reducing power, and acetyl-
CoA to produce PHB, so the TCA cycle is an important pathway to include in the model. 




Figure 2. The metabolic pathway for the TCA cycle. 
 
Reaction 4: 
                             
                
↔                          
 
Enzyme: Citrate synthase 
 
Citrate synthase catalyzes the Claisen condensation reaction that forms citrate 
from oxaloacetate and acetyl-CoA. Citrate synthase is controlled through activators and 
inhibitors. Acetyl-CoA acts as an allosteric activator and K
+
 acts as a non-allosteric 
inhibitor. Allosteric inhibitors include NADH, NAD
+
, and oxaloacetate. ATP and 2-
oxoglutarate act as competitive inhibitors. Other inhibitors include citrate, isocitrate, and 
cis-aconitate (Anderson & Duckworth, 1988; Duckworth et al, 1987; Man et al, 1995; 
Senior & Dawes, 1973; Walsh & Koshland, 1985). 





Studies have demonstrated sequential ordered bi-bi kinetics, with oxaloacetate 
binding first, in E. coli for this reaction (Anderson & Duckworth, 1988). Studies have 
also demonstrated that citrate synthase exhibits competitive inhibition with 2-
oxoglutarate (Anderson & Duckworth, 1988; Pereira et al, 1994). 
An ordered bi-bi kinetic mechanism, Equation (3), was used to model the forward 
reaction catalyzed by citrate synthase. Substrate A was oxaloacetate and substrate B was 
acetyl-CoA. Kinetic parameters utilized in the model are shown in Table IV. The values 
chosen were from various strains of E. coli. 
 
Table IV. Kinetic parameters utilized for Reaction 4 in the model. 









E. coli H229Q 
E. coli H226Q 
E. coli wild 
Anderson & Duckworth, 1988 
Anderson & Duckworth, 1988 







E. coli H229Q 
E. coli H226Q 
E. coli wild 
Anderson & Duckworth, 1988 
Anderson & Duckworth, 1988 










E. coli H229Q 
E. coli H226Q 
E. coli wild 
Anderson & Duckworth, 1988 
Anderson & Duckworth, 1988 









Matsuoka & Srere, 1973 







Matsuoka & Srere, 1973 
Mukherjee et al, 1980 




No kinetic data were found for the reverse of Reaction 4 in E. coli. Studies of the 
citrate synthase in rat kidneys and the human heart provided kinetic parameters for the 
reverse reaction catalyzed by citrate synthase (Matsuoka & Srere, 1973; Mukherjee et al, 
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1980).  Studies suggest that a random bi-bi mechanism is employed by this reaction 
(Matsuoka & Srere, 1973). Equation (5) represents a random bi-bi kinetic mechanism. 
Therefore, Equation (5) and the kinetic parameters in Table IV were used to model the 



























              (5) 
   
 VMAX  = kcat*[E] = [µM/s] 
 KA = Dissociation constant for substrate A = [µM] 
 KB =  Dissociation constant for substrate B = [µM] 
 kcat  =  Maximum number of rxns catalyzed per second = [s
-
]  
 [A]  =  Concentration of substrate A = [µM] 
 [B] =  Concentration of substrate B = [µM] 
 [E] =  Concentration of enzyme = [µM] 
 α =  Binding interaction factor 
  If α = 1, substrate binding is independent 
  If α > 1, binding of substrate decreases affinity of other 
  If α < 1, binding of substrate increases affinity of other 
 
Reaction 5: 
        
                   
↔                          
 
Enzyme: Citrate hydro-lyase 
 
Citrate hydro-lyase is an aconitase that catalyzes the reversible isomerization of 
citrate. E. coli has two major aconitases, AcnA and AcnB. AcnA is the aerobic-stationary 
phase enzyme, and AcnB is the major TCA cycle enzyme during exponential growth. 
AcnA is more stable than AcnB, and has a higher affinity for citrate. AcnB is the main 
catabolic enzyme because its sensitivity to oxidative or pH stress allows it to regulate the 
TCA cycle (Jordan et al, 1999). 





Studies indicate that this reaction exhibits normal Michaelis-Menten kinetics. 
Equation (4) was used to model the forward reaction. Kinetic parameters were found for 
both AcnA and AcnB as seen in Table V. It was decided to use AcnB values for this 




Studies indicate that this reaction exhibits Michaelis-Menten kinetics with a Hill 
cooperativity factor of 2.1 (Tsuchiya et al, 2009). Equation (6) represents Hill kinetics 

















              (6) 
  
 VMAX  =  kcat*[E] = [µM/s] 
 KM =  Substrate concentration resulting in 0.5VMAX = [µM] 
 kcat  =  Maximum number of rxns catalyzed per second = [s
-
] 
 [S]  =  Concentration of substrate = [µM] 
 [E] =  Concentration of enzyme = [µM] 
 n =  Hill cooperativity coefficient 
 
 
Table V. Kinetic parameters utilized for Reaction 5 in the model. 









E. coli K-12 MG1655 
E. coli K-12 MG1655 
Jordan et al, 1999 







E. coli K-12 MG1655 
E. coli K-12 MG1655 
Jordan et al, 1999 










E. coli K-12 MG1655 
E. coli K-12 MG1655 
Jordan et al, 1999 








E. coli K-12 MG1655 
E. coli K-12 MG1655 
Jordan et al, 1999 
Jordan et al, 1999 








              
                      
↔                         
 
Enzyme: Isocitrate hydro-lyase 
 
Isocitrate hydro-lyase is an aconitase that catalyzes the reversible isomerization of 




Studies show that this reaction exhibits normal Michaelis-Menten kinetics with 
negative cooperativity (Jordan et al, 1999; Tsuchiya et al, 2009). Equation (6) was used 
to model the forward reaction. Kinetic parameters were found for both AcnA and AcnB 
as seen in Table VI. AcnB values were used for this model because AcnB is the major 
TCA cycle enzyme (Jordan et al, 1999). 
 
Table VI. Kinetic parameters utilized for Reaction 6 in the model. 









E. coli K-12 MG1655 
E. coli K-12 MG1655 
Jordan et al, 1999 








E. coli K-12 MG1655 
E. coli K-12 MG1655 
Jordan et al, 1999 
Jordan et al, 1999 










E. coli K-12 MG1655 
E. coli K-12 MG1655 
Jordan et al, 1999 







E. coli K-12 MG1655 
E. coli K-12 MG1655 
Jordan et al, 1999 












Studies indicate that this reaction exhibits Michaelis-Menten kinetics (Jordan et 
al, 1999). Equation (4) was used to model the reverse reaction. Kinetic parameters were 
found for both AcnA and AcnB as seen in Table VI. AcnB values were used for this 
model because AcnB is the major TCA cycle enzyme (Jordan et al, 1999). 
 
Reaction 7: 
                 
                        
→                                           
 
Enzyme: Isocitrate dehydrogenase 
 
Isocitrate dehydrogenase catalyzes the irreversible oxidative decarboxylation of 
isocitrate to 2-oxoglutarate. The enzyme is regulated by phosphorylation and 
dephosphorylation. Isocitrate is important because it allows E. coli to switch between the 




Studies indicate that the reaction catalyzed by isocitrate dehydrogenase displays 
normal Michaelis-Menten kinetics (Lee et al, 1995). Therefore, Equation (4) was used to 
model the reaction utilizing the kinetic parameters from Table VII. 
 
Table VII. Kinetic parameters utilized for Reaction 7 in the model. 













E. coli K230M 
E. coli Y160F 
Lee et al, 1995 
Lee et al, 1995 
Lee et al, 1995 












E. coli K230M 
E. coli Y160F 
Lee et al, 1995 
Lee et al, 1995 
Lee et al, 1995 




                       
                            
→                                           
 
Enzyme: 2-oxoglutarate dehydrogenase complex 
 
The 2-oxoglutarate dehydrogenase complex catalyzes the irreversible oxidative 
decarboxylation of 2-oxoglutarate to succinyl-CoA. The complex contains three 
components: 2-oxoglutarate decarboxylase (E1), lipoamide acyltransferase (E2), and 




The net forward reaction demonstrated normal Michaelis-Menten kinetics 
(McCormack & Denton, 1981). The kinetic parameters in Table VIII were used with 
Equation (4) to model the forward reaction. 
 
Table VIII. Kinetic parameters utilized for Reaction 8 in the model. 











McCormack & Denton, 1981 
McCormack & Denton, 1981 
Vm 0.00363 µM /s E. coli McCormack & Denton, 1981 
 
Reaction 9: 
                      
                       
↔                                   
 
Enzyme: Succinyl-CoA synthetase 
 
Succinyl-CoA synthetase catalyzes substrate level phosphorylation in the TCA 
cycle by converting succinyl-CoA and ADP into succinate and ATP. In E. coli, the 
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enzyme exists as a tetramer and favors adenine over guanine nucleotides. In eukaryotes, 
guanine nucleotides are preferred (Birney et al, 1996). It is a multiple step reaction that 
uses a covalent enzyme-substrate intermediate. The phosphate group is transferred to the 




In the forward reaction, enzyme bound succinyl-phosphate is formed as an 
intermediate. The phosphate group is transferred to a histidine residue and succinate is 
released as a product. The phosphoenzyme then generates the second product, ATP. 
The kinetic mechanism behind this reaction is not well understood. The reaction 
is similar to many reactions classified as ping-pong, but some studies support a sequential 
mechanism and the formation of a quaternary structure. Studies indicate that ADP is an 
allosteric regulator of the enzyme during the forward reaction (Um & Klein, 1993). The 
reaction displays an unusual catalytic property called substrate synergism. The presence 
of a substrate for one reaction stimulates another reaction. The exact mechanism for 
substrate synergism has yet to be defined in terms of an equation (Birney et al, 1996; Um 
& Klein, 1993). 
Due to the lack of a kinetic mechanism and parameters, this reaction was modeled 
by using simple mass-action kinetics. It is hoped that future studies can provide a more 




The reverse reaction also has unusual catalytic properties, but some studies 
supported a sequential mechanism and were able to measure some kinetic parameters 
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(Joyce et al, 1999; Luo & Nishimura, 1991; Moffet & Bridger, 1970). An ordered bi-bi 
mechanism, Equation (3), was used to model the reverse reaction with substrate A as 
succinate and substrate B as CoA. The parameters shown in Table IX were used for 
Reaction 9 of the model. 
 
Table IX. Kinetic parameters utilized for Reaction 9 in the model. 

















Luo & Nishimura, 1991 
Luo & Nishimura, 1991 










Luo & Nishimura, 1991 
Luo & Nishimura, 1991 





 E. coli Joyce et al, 1999 
 
Reaction 10: 
              
                       
↔                                  
 
Enzyme: Succinate dehydrogenase 
 
Succinate dehydrogenase catalyzes the oxidation of succinate to fumarate under 
aerobic conditions. It can also catalyze the reverse reaction, the reduction of fumarate to 
succinate. Succinate dehydrogenase requires flavins, ubiquinone, or menaquinol as 




The oxidation of succinate to fumarate has demonstrated normal Michaelis-
Menten kinetics in studies of E. coli (Cecchini et al, 2002; Maklashina et al, 2006). One 
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study indicated that succinate dehydrogenase was inhibited by oxaloacetate and 
malonate, but no mechanism was identified (Maklashina et al, 2006). This model utilized 
a noncompetitive inhibition mechanism, Equation (7), with oxaloacetate as the inhibitor. 
Kinetic parameters utilized in this model are shown in Table X. 
 
























MAX      (7) 
  
 VMAX  =  kcat*[E] = [µM/s] 
 KM =  Substrate concentration resulting in 0.5VMAX = [µM] 
 Ki = Inhibitor concentration in 0.5VMAX = [µM] 
 kcat  =  Maximum number of rxns catalyzed per second = [s
-
] 
 [S]  =  Concentration of substrate = [µM] 
 [E] =  Concentration of enzyme = [µM] 




The reduction of fumarate to succinate has displayed normal Michaelis-Menten 
kinetics in E. coli (Cecchini et al, 2002; Maklashina et al, 2006). This model utilized 
Equation (4) to simulate this reaction. Kinetic parameters utilized in this model are shown 
in Table X. 
 
Table X. Kinetic parameters utilized for Reaction 10 in the model. 









Maklashina et al, 2006 
Cecchini et al, 2002 
Ki 0.07
 









Maklashina et al, 2006 









Maklashina et al, 2006 









Maklashina et al, 2006 
Cecchini et al, 2002 





            
        




Fumarase catalyzes the reaction between fumarate and malate in the TCA cycle. 
There are three fumarase isozymes in E. coli. Fumarase A has the most activity under 
microaerophilic condition and is inactivated under aerobic conditions. Fumarase B has 
some activity in microaerophilic and aerobic conditions. Fumarase B also has a higher 
affinity for malate than fumarate. Fumarase C is highly active under aerobic conditions 
(Woods et al, 1988). 
 
Forward and Reverse Reaction: 
 
No kinetic mechanism was identified for Reaction 11. Normal Michaelis-Menten 
kinetics were assumed for the forward and reverse reactions. Equation (4) and the kinetic 
parameters in Table XI were utilized in the model of the forward and reverse reactions. 
 
Table XI. Kinetic parameters utilized for Reaction 11 in the model. 
 Parameter Value Units Organism Reference 
Fwd Rxn 
Km 100 µM E. coli Rose & Weaver, 2004 
kcat 60 s
- 
E. coli Rose & Weaver, 2004 
Rev Rxn 
Km 300 µM E. coli Rose & Weaver, 2004 
kcat 129 s
- 
E. coli Rose & Weaver, 2004 
 
Reaction 12: 
           
                    
↔                                   
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Enzyme: Malate dehydrogenase 
 
Malate dehydrogenase catalyzes the reversible oxidation of malate to 
oxaloacetate. The enzyme uses NAD
+
 as an electron acceptor. The activity of malate 




Studies indicate that this reaction follows an ordered bi-bi mechanism (Heyde & 
Ainsworth, 1968; Muslin et al, 1995). Equation (3) was used to model the forward 
reaction with substrate A as malate and substrate B as NAD
+
. The kinetic parameters 




It was assumed that the reverse reaction would also follow an ordered bi-bi 
mechanism, so Equation (3) was employed to model the reaction with substrate A as 
oxaloacetate and substrate B as NADH. The kinetic parameters found in Table XII were 
used to model this reaction. 
 
Table XII. Kinetic parameters utilized for Reaction 12 in the model. 
 Parameter Value Units Organism Reference 
Fwd 
Rxn 
KA 2600 µM E. coli Muslin et al, 1995 
KB 260 µM E. coli Muslin et al, 1995 
kcat 21 s
- 
E. coli Muslin et al, 1995 
Rev 
Rxn 
KA 49 µM E. coli Muslin et al, 1995 
KB 61 µM E. coli Muslin et al, 1995 
kcat 900 s
- 
E. coli Muslin et al, 1995 




The glyoxylate pathway is a shunt in the TCA cycle. It is composed of two 
reactions catalyzed by the enzymes isocitrate lyase and malate synthase shown in Figure 
3. Using additional acetyl-CoA, this pathway can convert isocitrate into malate and 
succinate bypassing the conversion into 2-oxoglutarate and succinyl-CoA. This shunt 
generates intermediates to be used elsewhere in the cell, but fails to generate the energy 
and reducing power that is generated when isocitrate continues through the TCA cycle. 
The glyoxylate shunt is included in this model to more accurately represent the energy 
and reducing power generated in the TCA cycle. 
 
 
Figure 3. The metabolic pathway for the glyoxylate shunt in the TCA cycle.  




          
                
↔                               
 
Enzyme: Isocitrate lyase 
 
Isocitrate lyase catalyzes the cleavage of isocitrate into glyoxylate and succinate. 




 Isocitrate lyase cleaves isocitrate into glyoxylate and succinate in the forward 
direction. The pH in E. coli cells is around 7.3 to 7.6 (Mackintosh & Nimmo, 1988); 
therefore, the parameters measured at pH = 7.3 were utilized in the model. 
Phosphoenolpyruvate acts as a non-competitive inhibitor, but the Ki value suggests it is 
not significant in vivo. The species 3-phosphoglycerate is a competitive inhibitor of 
isocitrate lyase and is more significant due to its higher concentrations in the cell 
(Mackintosh & Nimmo, 1988). Equation (8) was used to model the competitive inhibition 




























             (8) 
  
 VMAX  =  kcat*[E] = [µM/s] 
 KM =  Substrate concentration resulting in 0.5VMAX = [µM] 
 Ki = Inhibitor concentration in 0.5VMAX = [µM] 
 kcat  =  Maximum number of rxns catalyzed per second = [s
-
] 
 [S]  =  Concentration of substrate = [µM] 
 [E] =  Concentration of enzyme = [µM] 
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Table XIII. Kinetic parameters utilized for Reaction 13 in the model. 









E. coli ML308 
E. coli ML308 
Mackintosh & Nimmo, 1988 
















E. coli ML308 
E. coli ML308 
E. coli ML308 
E. coli ML308 
Mackintosh & Nimmo, 1988 
Mackintosh & Nimmo, 1988 
Mackintosh & Nimmo, 1988 







E. coli ML308 
C. acremonium 
Robertson & Nimmo, 1995 
Perdiguero et al, 1995 
Rev 
Rxn 
KA 590 µM E. coli ML308 Mackintosh & Nimmo, 1988 
KB 130 µM E. coli ML308 Mackintosh & Nimmo, 1988 
kcat 15.7 s
-
 C. acremonium Perdiguero et al, 1995 
a. pH = 7.3 




Isocitrate lyase condenses glyoxylate and succinate into isocitrate in the reverse 
reaction. This reaction occurs by a sequential random-order equilibrium mechanism 
where the substrate binding of glyoxylate and succinate are independent (Mackintosh & 
Nimmo, 1988). Equation (5) and the parameters in Table XIII were used to model the 
reaction with substrate A as succinate and substrate B as glyoxylate. 
 
Reaction 14: 
                           
               
→                         
 
Enzyme: Malate synthase 
 
Malate synthase exists as two isozymes in E. coli. Malate synthase A is the 
enzyme utilized in the glyoxylate shunt in the TCA cycle. Malate synthase A catalyzes 
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the irreversible reaction of glyoxylate and acetyl-CoA into malate. Malate synthase B 




Malate synthase catalyzes the Claisen condensation of glyoxylate and acetyl-CoA 
into a malyl-CoA intermediate. The malyl-CoA intermediate is then cleaved into the two 
products, malate and CoA. Pyruvate is a competitive inhibitor to malate synthase 
(Anstrom et al, 2003). Studies indicate that this reaction proceeds through a random 
sequential mechanism with independent substrate binding. Equation (5) and the kinetic 
parameters shown Table XIV were used to model the reaction with substrate A as 
glyoxylate and substrate B as acetyl-CoA. 
 
Table XIV. Kinetic parameters utilized for Reaction 14 in the model. 









Anstrom et al, 2003 













Anstrom et al, 2003  
Durchschlag et al, 1981 
Anstrom et al, 2003 
α 1.0 - S. cerevisiae Durchschlag et al, 1981 
kcat 48.1 s
- 








Glycolysis is the metabolic pathway that breaks down glucose into pyruvate while 
generating a small amount of energy and reducing power. Glycolysis is composed of ten 
reactions seen in Figure 4. The enzymes that catalyze these ten reactions are glucokinase, 
phosphoglucose isomerase, 6-phosphofructokinase, fructose-bisphosphate aldolase, triose 
phosphate isomerase, glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerate 
kinase, phosphoglycerate mutase, enolase, and pyruvate kinase. Cofactors that participate 
in glycolysis are ADP/ATP, NADH/NAD
+
, and Pi. Glycolysis was included in this model 
because glucose is a common substrate used to grow cells and produce PHB.  
Gluconeogenesis is a metabolic pathway that can convert pyruvate back into 
glucose. It includes many of the same enzymes as glycolysis. Gluconeogenesis uses five 
additional enzymes: glucose-1-phosphatase, phosphoglucomutase, fructose-1,6-
bisphosphatase, phosphoenolpyruvate carboxykinase, and phosphoenolpyruvate 
synthetase. Gluconeogenesis includes 12 reactions as shown in Figure 4. 
Gluconeogenesis was included in this model to account for the conversion of pyruvate 
into glucose. Gluconeogenesis can occur when the concentrations of acetyl-CoA and 





            
           
→                                    
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igure 4. The metabolic pathway for glycolysis and gluconeogenesis. 
The forward reaction is catalyzed by the enzyme glucokinase. Glucokinase 
phosphorylates glucose into the product glucose-6-phosphate. The reaction requires ATP 
to proceed. The kinetic mechanism for glucokinase has been studied in several organisms 
such as Z. mobilis and P. shermanii. It is hypothesized that the mechanism will be the 
same in E. coli because it is consistent with the crystal structure of the E. coli 
glucokinase. Studies indicate that the mechanism is a preferred order of substrate addition 
and product release. Glucose is added first followed by ATP (Lunin et al, 2004). An 
ordered bi-bi mechanism, Equation (3), was used to model the forward reaction with the 




The conversion of glucose-6-phosphate back into glucose is a two step process 
that involves two enzymes: phosphoglucomutase and glucose-1-phosphatase. 
 
Step 1: 
                   
                  
↔                                 
 
 
Step one is a reversible reaction catalyzed by phosphoglucomutase where 
glucose-6-phosphate is converted into glucose-1-phosphate via the intermediate glucose-
1,6-diphosphate. No kinetic data were found for E. coli in the direction of glucose-6-
phosphate to glucose-1-phosphate, but there was kinetic data from phosphoglucomutase 
in rat heart cells. Normal Michaelis-Menten kinetics, Equation (4), were assumed and 
kinetic parameters found in Table XV were utilized in the model. 
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A thermophilic phosphoglucomutase that was similar to the E. coli enzyme 
demonstrated a ping-pong catalytic mechanism in the direction of glucose-1-phosphate to 
glucose-6-phosphate (Yoshizaki et al, 1971). Other studies have also suggested a ping-
pong mechanism (Ray & Roscelli, 1964). It was decided to use normal Michaelis-Menten 
kinetics for the reverse direction of Step 1 to simplify the model. Equation (4) was 
utilized along with the kinetic parameters found in Table XV. 
 
Step 2: 
                       
                     
→                           
 
 
Step 2 is an irreversible reaction where glucose-1-phosphate is converted into 
glucose by the enzyme glucose-1-phophatase. Normal Michaelis-Menten kinetics, 
Equation (4), were used to model the reaction with the parameters found in Table XV. 
 
Table XV. Kinetic parameters utilized for Reaction 15 in the model. 
 Parameter Value Units Organism Reference 
Fwd 
Rxn 
KA 780 µM E. coli Meyer et al, 1997 
KB 3760 µM
 
E. coli Meyer et al, 1997 
Vm 2.643 µM/s E. coli Meyer et al, 1997 
Rev Rxn 
Step 1 Fwd 
KM 670 µM Rat heart Kashiwaya et al, 1994 
Vm 1.12 µM/s Rat heart Kashiwaya et al, 1994 
Rev Rxn 







Josh & Handler, 1964 
Dworniczak et al, 2008  
Vm 0.001 µM /s
 
E. coli Dworniczak et al, 2008 
Rev Rxn 
Step 2 
Km 240 µM E. coli Kuznetsova et al, 2006 
kcat 1.4 s
- 
E. coli Kuznetsova et al, 2006 
 
Reaction 16: 
                   
                        
↔                                      
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Enzyme: Phosphoglucose isomerase 
 
Reaction 16 is a reversible reaction catalyzed by the enzyme phosphoglucose 
isomerase. The enzyme converts glucose-6-phosphate into fructose-6-phosphate or vice 
versa.  
 
Forward and Reverse Reaction: 
 
A study in E. coli indicated that the kinetic mechanism utilized in this reaction 
was a uni-uni reversible that utilized the Haldane relationship (Ishii et al, 2007). Equation 
(9) and the kinetic parameters shown in Table XVI were used to model this reaction. 
Glucose-6-phosphate was used as substrate A, and fructose-6-phosphate was used as 
substrate B. The reverse reaction uses the same kinetics as the forward reaction (Ishii et 















































       (9) 
  
 VMAX  =  kcat*[E] = [µM/s] 
 KA = Dissociation constant for substrate A = [µM] 
 KB =  Dissociation constant for substrate B = [µM] 
 kcat  =  Maximum number of rxns catalyzed per second = [s
-
]  
 Keq = Equilibrium constant [unitless] 
 [A]  =  Concentration of substrate A = [µM] 
 [B] =  Concentration of substrate B = [µM] 
 [E] =  Concentration of enzyme = [µM] 
 
 
Table XVI. Kinetic parameters utilized for Reaction 16 in the model. 
 Parameter Value Units Organism Reference 
Fwd 
Rxn 
KA 3000 µM E. coli K-12 Ishii et al, 2007 
KB 160 µM E. coli K-12 Ishii et al, 2007 
Keq 0.3 - E. coli K-12 Ishii et al, 2007 
Vm 25.18 µM/s E. coli K-12 Ishii et al, 2007 






                        
                     




The ATP dependent 6-phosphofructokinase catalyzes the phosphorylation of 
fructose-6-phosphate into fructose-1,6-bisphosphate. An ordered bi-bi reaction 
mechanism has been proposed for this reaction in E. coli with fructose-6-phosphate as 
substrate A and ATP as substrate B (Campos et al, 1984). Equation (3) and the kinetic 
parameters shown in Table XVII were utilized in the model of the forward direction of 
Reaction 17.  
 
Reverse Reaction: 
                             
                           




Fructose-1,6-bisphosphatase catalyzes the dephosphorylation of fructose-1,6-
bisphosphate to fructose-6-phosphate. There are four major genes that encode for 
fructose-1,6-bisphosphatase in E. coli: fbp, yphA, yggF, glpX. Fbp is the main fructose-
1,6-bisphosphatase in the cell. YggF and GlpX are type II fructose-1,6-bisphosphatases. 
Hill kinetics have been shown for this reaction in E. coli with a cooperativity 
factor of 2.0 (Brown et al, 2009). Equation (6) and the kinetic parameters shown in Table 
XVII were used to model the reverse direction of Reaction 17. Values for all four 
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fructose-1,6-bisphosphatases are shown in Table XVII but only values for Fbp were used 
in the model. 
 
Table XVII. Kinetic parameters utilized for Reaction 17 in the model. 









Wang & Kemp, 1999 







Wang & Kemp, 1999 
Campos et al, 1984 
kcat 82 s
- 





















Brown et al, 2009 
Brown et al, 2009 
Brown et al, 2009 




















Brown et al, 2009 
Brown et al, 2009 
Brown et al, 2009 

























Brown et al, 2009 
Brown et al, 2009 
Brown et al, 2009 
Brown et al, 2009 
n 2.0 -
 
E. coli Brown et al, 2009 
a. Fbp fructose-1,6-bisphosphatase 
b. YbhA fructose-1,6-bisphosphatase 
c. YggF fructose-1,6-bisphosphatase 
d. GlpX fructose-1,6-bisphosphatase 
 
Reaction 18: 
                         
                              
↔                     
                                                       
 
Enzyme: Fructose-bisphosphate aldolase 
 
Fructose-bisphosphate aldolase catalyzes the aldol cleavage of fructose-1,6-
bisphosphate into dihydroxyacetone phosphate and glyceraldehyde-3-phosphate. 






Normal Michaelis-Menten kinetics were observed for the cleavage of fructose-
1,6-bisphosphate in E. coli (Plater et al, 1999). Equation (4) and the kinetic parameters 




The reverse reaction proceeds via a ping-pong mechanism (Lambeth & 
Kushmerick, 2002). Equation (2) and the kinetic parameters in Table XVIII were used to 
model the reverse reaction in SimBiology. Substrate A was dihydroxyacetone phosphate 
and substrate B was glyceraldehyde-3-phosphate in the model. 
 
Table XVIII. Kinetic parameters utilized for Reaction 18 in the model. 
 Parameter Value Units Organism Reference 
Fwd 
Rxn 
Km 230 µM E. coli Plater et al, 1999 
kcat 0.07 s
- 
E. coli Plater et al, 1999 
Rev 
Rxn 
KA 2100 µM Rabbit  Lambeth & Kushmerick, 2002 
KB 1100 µM Rabbit Lambeth & Kushmerick, 2002 
Vm 1733 µM /s
 
Rabbit Lambeth & Kushmerick, 2002 
 
Reaction 19: 
                          
                          
↔                                             
 
Enzyme: Triose phosphate isomerase 
 
Triose phosphate isomerase catalyzes the conversion of dihydroxyacetone 
phosphate into glyceraldehyde-3-phosphate via a cis-ene-diolate intermediate. Triose 
phosphate isomerase is considered to be a perfect enzyme. 
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Forward and Reverse Reaction: 
 
The forward and reverse reactions are expressed by normal Michaelis-Menten 
kinetics (Nickbarg & Knowles, 1988). Equation (4) and the parameters in Table XIX 
were used to model the reaction. 
 
Table XIX. Kinetic parameters utilized for Reaction 19 in the model. 
 Parameter Value Units Organism Reference 
Fwd 
Rxn 
Km 2300 µM E. coli Nickbarg & Knowles, 1988 
Keq 750 µM E. coli Nickbarg & Knowles, 1988 
kcat 750 s
- 
E. coli Nickbarg & Knowles, 1988 
Rev 
Rxn 
Km 320 µM Rabbit Lambeth & Kushmerick, 2002 
Vm 200 µM /s
 
Rabbit Lambeth & Kushmerick, 2002 
 
Reaction 20: 
                                   
                                        
↔                               
                                 
 
Enzyme: Glyceraldehyde-3-phosphate dehydrogenase 
 
The enzyme glyceraldehyde-3-phosphate dehydrogenase catalyzes the reversible 
oxidation of glyceraldehyde-3-phosphate into 1,3-diphosphateglycerate. The cofactor 
NAD
+




The forward reaction proceeds via a sequential ordered ter-bi mechanism (Wang 
& Alaupovic, 1980). Ordered ter-bi reactions can be represented by the ordered ter-ter 
kinetic expression for steady-state and rapid equilibrium kinetics (Purich & Allison, 
2000). Equation (10) and the kinetic parameters found in Table XX were used to model 
  40 
 
 
the forward reaction in SimBiology. In the equation, substrate A was NAD
+
, substrate B 
was glyceraldehyde-3-phosphate, and substrate C was inorganic phosphate. 
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 VMAX  =  kcat*[E] = [µM/s] 
 KA = Dissociation constant for substrate A = [µM] 
 KB =  Dissociation constant for substrate B = [µM] 
 KC =  Dissociation constant for substrate C = [µM] 
 KiA = Binding constant for substrate A = [µM] 
 KiB =  Binding constant for substrate B = [µM] 
 KiC =  Binding constant for substrate C = [µM] 
 kcat  =  Maximum number of rxns catalyzed per second = [s
-
]  
 [A]  =  Concentration of substrate A = [µM] 
 [B] =  Concentration of substrate B = [µM] 
 [C] =  Concentration of substrate C = [µM] 
 [E] =  Concentration of enzyme = [µM] 
 
Table XX. Kinetic parameters utilized for Reaction 20 in the model. 
 Parameter Value Units Organism Reference 
Fwd 
Rxn 







Crow & Wittenberger, 1979 
Lambeth & Kushmerick, 2002 
KC 290 µM Rabbit Lambeth & Kushmerick, 2002 
Vm 0.38 µM/s S. mutans Crow & Wittenberger, 1979 
Rev 
Rxn 
KA 0.8 µM Rabbit Lambeth & Kushmerick, 2002 
KB 3.3 µM Rabbit Lambeth & Kushmerick, 2002 
Vm 21.08 µM /s
 




The reverse reaction has a sequential ordered bi-ter mechanism (Wang & 
Alaupovic, 1980). Ordered bi-ter reactions can be represented by the ordered bi-bi kinetic 
expression for steady-state and rapid equilibrium kinetics (Purich & Allison, 2000). 
Equation (3) and the kinetic parameters found in Table XX were used to model the 
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forward reaction in SimBiology. Substrate A was set as 1,3-diphosphateglycerate and 
substrate B was set as NADH. 
 
Reaction 21: 
                                
                       
↔                                        
 
Enzyme: Phosphoglycerate kinase 
 
Phosphoglycerate kinase catalyzes the phosphoryl group transfer from 1,3-




The forward reaction catalyzed by phosphoglycerate kinase follows a sequential 
random bi-bi mechanism (Lavoinne et al, 1983). Equation (5) and the kinetic parameters 
in Table XXI were used to model the reaction. Substrate binding was assumed to be 
independent with substrate A as 1,3-diphosphateglycerate and substrate B as ADP. 
 
Table XXI. Kinetic parameters utilized for Reaction 21 in the model. 
 Parameter Value Units Organism Reference 
Fwd 
Rxn 
KA 2.2 µM Rabbit Lambeth & Kushmerick, 2002 
KB 50 µM Pig Lambeth & Kushmerick, 2002 
Vm 18.7 µM/s Pig Lambeth & Kushmerick, 2002 
Rev 
Rxn 
KA 1200 µM Pig Lambeth & Kushmerick, 2002 
KB 360 µM Rabbit Lambeth & Kushmerick, 2002 
Vm 18.7 µM/s
 




The reverse reaction catalyzed by phosphoglycerate kinase also follows a 
sequential random bi-bi mechanism (Lavoinne et al, 1983). Equation (5) and the kinetic 
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parameters in Table XXI were used to model the reaction. Substrate binding was assumed 
to be independent with substrate A as 3-phosphoglycerate and substrate B as ATP. 
 
Reaction 22: 
                      
                      
↔                                   
 
 
Enzyme: Phosphoglycerate mutase 
 
Phosphoglycerate mutase catalyzes the intramolecular phosphoryl group transfer 
to form 2-phosphoglycerate from 3-phosphoglycerate. A histidine-phosphoenzyme 
intermediate is formed during the reaction. 
 
Forward and Reverse Reaction: 
 
No kinetic mechanism was identified in the literature for Reaction 22; therefore, 
normal Michaelis-Menten kinetics were assumed for the reaction in SimBiology. 
Equation (4) and the kinetic parameters in Table XXII were used to model Reaction 22. 
 
Table XXII. Kinetic parameters utilized for Reaction 22 in the model. 







E. coli dPGM 
E. coli iPGM 
Fraser et al, 1999 







E. coli dPGM 
E. coli iPGM 
Fraser et al, 1999 







E. coli dPGM 
E. coli iPGM 
Fraser et al, 1999 







E. coli dPGM 
E. coli iPGM 
Fraser et al, 1999 
Fraser et al, 1999 
 
 




                  
       





Enolase catalyzes the dehydration of 2-phosphoglycerate that produces the high 
energy compound phosphoenolpyruvate. 
 
Forward and Reverse Reaction: 
 
No kinetic mechanism was identified for Reaction 23. Both reactions were 
assumed to proceed via normal Michaelis-Menten kinetics. Equation (4) and the kinetic 
parameters shown in Table XXIII were used to model the reaction in SimBiology. 
 
Table XXIII. Kinetic parameters utilized for Reaction 23 in the model. 









Spring & Wold, 1971 
Lambeth & Kushmerick, 2002 
Vm 3 µM/s E. coli Spring & Wold, 1971 
Rev 
Rxn 
Km 370 µM Rat Lambeth & Kushmerick, 2002 
Vm 3.2 µM/s
 




                             
               
→                        
 
Enzyme: Pyruvate kinase 
 
The forward reaction is catalyzed by pyruvate kinase and has been shown to have 
a sequential random bi-bi mechanism (Giles et al, 1976; Waygood et al, 1976). Equation 
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(5) and the kinetic parameters found in Table XXIV were used to model the reaction in 




                
                              
→                                                     
 
Enzyme: Phosphoenolpyruvate synthetase 
 
The reverse reaction is catalyzed by phosphoenolpyruvate synthetase and 
proceeds via a ping-pong mechanism (Sigman, 1990). Equation (2) and the values in 
Table XXIV were used in the model with substrate A as pyruvate and substrate B as 
ATP. 
 
Table XXIV. Kinetic parameters utilized for Reaction 24 in the model. 









Valentini et al, 2000 







Valentini et al, 2000 









Valentini et al, 2000 
Valentini et al, 2000 
Rev 
Rxn 
KA 7050 µM Rabbit Lambeth & Kushmerick, 2002 
KB 820 µM Rabbit Lambeth & Kushmerick, 2002 
Vm 24 µM/s
 
Rabbit Lambeth & Kushmerick, 2002 
 
Reaction 25: 
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Enzyme: Phosphoenolpyruvate carboxykinase 
 
Phosphoenolpyruvate carboxykinase catalyzes the irreversible conversion of 
oxaloacetate into phosphoenolpyruvate via a sequential random bi-bi mechanism (Krebs 
& Bridger, 1980). Equation (5) and the kinetic parameters shown in Table XXV were 
used to model this reaction in SimBiology. Substrate binding was assumed to be 
independent with substrate A as oxaloacetate and substrate B as ATP. 
 
Table XXV. Kinetic parameters utilized for Reaction 25 in the model. 
 Parameter Value Units Organism Reference 
Fwd 
Rxn 
KA 670 µM E. coli Krebs & Bridger, 1980 
KB 60 µM E. coli Krebs & Bridger, 1980 
Vm 0.02 µM/s
 




 Acetyl-CoA synthesis is a metabolic pathway composed of one reaction. This 
reaction is catalyzed by the enzyme complex pyruvate dehydrogenase as shown in Figure 
5. This reaction converts pyruvate into acetyl-CoA with the help of the cofactor CoA. 
This pathway was included in the model because of the use of acetyl-CoA as the starting 
substrate in the PHB synthesis pathway. 
 
 
Figure 5. The metabolic pathway for acetyl-CoA synthesis. 




                  
                      
→                                     
 
Enzyme: Pyruvate dehydrogenase complex 
 
The pyruvate dehydrogenase complex catalyzes an irreversible reaction to 
produce acetyl-CoA from pyruvate, the product of glycolysis. It is a large, multienzyme 
complex composed of three distinct types of enzyme. The pyruvate dehydrogenase 









In the first step, pyruvate is decarboxylated after it combines with TPP. This stage 
of the reaction is catalyzed by the pyruvate dehydrogenase component of the complex 
(E1). This step exhibits tight-binding inhibition with thiamine 2-thiazolone diphosphate 
(ThTDP), and with thiamine 2-thiothiazolone diphosphate (ThTTDP) (Liu & Bisswanger, 
2003; Nemeria et al, 2001).   
 
             
  





In the second step, the hydroxyethyl attached to the TPP is oxidized to form an 
acetyl group that is transferred to lipoamide. This stage of the reaction is also catalyzed 
by the pyruvate dehydrogenase component of the complex (E1) (Liu & Bisswanger, 
2003; Nemeria et al, 2001). 




                           
  





In the third step, the acetyl group is transferred from acetyllipoamide to CoA to 
form acetyl-CoA. Dihydrolipoyl transacetylase (E2) catalyzes this step (Snoep et al, 
1992; Willms et al, 1967). 
 
                      
  





In the fourth step, the oxidized lipoamide is regenerated using NAD
+
. This stage 
of the reaction is catalyzed by dihydrolipoyl dehydrogenase (E3) (Allison et al, 1988). 
 
                     
  




Kinetic studies on the pyruvate dehydrogenase complex from the bovine kidney 
have demonstrated that the overall reaction fits a random bi-bi mechanism as well as the 
Theorell-Chance mechanism (Butterworth et al, 1975). 
In E. coli, studies have shown that the first step catalyzed by the E1 component of 
the enzyme complex is the rate-limiting step (Liu & Bisswanger, 2003). Michaelis-
Menten kinetic parameters have been determined for the overall reaction in E. coli. 
Equation (4) and the parameters in Table XXVI were used to model the overall reaction 
in SimBiology. 
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Table XXVI. Kinetic parameters utilized for Reaction 26 in the model. 











Liu & Bisswanger, 2003 









Liu & Bisswanger, 2003 
Liu & Bisswanger, 2003 
a. H2O as solvent 
b. D2O as solvent 
  




 The transcriptional network associated with the enzymes in the selected metabolic 
pathways was included in the model. Enzymes are synthesized through the transcription 
and translation of genes. Cells regulate the amount of enzymes synthesized depending 
upon the needs of the cell. It is undesirable to waste energy synthesizing enzymes that are 
not needed. Transcription factors are regulatory proteins that can repress or induce 
transcription of genes. Cells use transcription factors to dynamically regulate the 
intracellular concentration of enzymes (Lehninger et al, 2008). 
 The first step in modeling the transcriptional network was to identify all the genes 
that contribute to the synthesis of the 30 enzymes used in Reactions 1-26. After the genes 
were known, then the next step was to determine which promoters initiated transcription 
of each gene. Next, the transcription factors associated with each promoter were 
identified. Only promoters that interact with transcription factors were included in the 
model. An equation was developed to calculate the rate of enzyme synthesis based on 
promoter activity and the concentrations of each transcription factor. Each promoter was 
represented by a reaction in the SimBiology model. 
 Ligand binding was also included in the model. Ligands that bind to each 
transcription factor were identified. Rules were used in SimBiology to calculate the 
concentration of active transcription factors based on the concentration of ligands. 
Reactions were also included to account for the degradation of enzymes that occurs in the 
cell. The end result of these equations and rules was a dynamic model of the 
concentration of 30 enzymes based on a transcriptional network. 
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Enzyme Genes and Promoters 
The enzyme genes were determined using the EcoCyc database (ecocyc.org) and 
the RegulonDB database (regulondb.ccg.unam.mx) for E. coli K12. These databases were 
used to identify the promoters that initiate transcription of each gene, and the regulatory 




The gene phaA encodes for the enzyme β-ketothiolase that catalyzes Reaction 1. 
The gene phaA is not naturally found in E. coli. The plasmid pBHR68 shown in Figure 6 
has been used to insert phaA, phaB, and phaC into E. coli (Linton, 2010). These three 
genes are transcribed using the lac promoter shown in Figure 6. The transcription factors 
Crp, H-NS, and LacI help regulate lac as shown in Figure 7. 
 
 




Figure 7. Transcription regulation summary diagram for the lac promoter from EcoCyc. 





The gene phaB encodes for the enzyme acetoacetyl-CoA reductase that catalyzes 
Reaction 2. The gene phaB is not found in the E. coli genome and is inserted using the 
plasmid pBHR68 shown in Figure 6. The promoter associated with phaB is the lac 




The gene phaC encodes for the enzyme poly-β-hydroxybutyrate polymerase that 
catalyzes Reaction 3. The gene phaC is added into E. coli by using the plasmid pBHR68 
shown in Figure 6. The lac promoter and the three transcription factors shown in Figure 7 




Citrate synthase is the enzyme that catalyzes Reaction 4, and it is encoded in the 
E. coli genome by the gene gltA. The transcription factors that regulate the transcription 
of gltA are Crp, IHF, and ArcA as shown in Figure 8. Figure 9 illustrates that there are 
two promoters for gltA, but only the promoter gltAp1 is affected by the transcription 
factors. Therefore, only the promoter gltAp1 was included in the model. 
 
 
Figure 8. Transcription regulation summary diagram for the gene gltA from EcoCyc. 








The gene acnA encodes for the aconitase A enzyme that can catalyze Reaction 5 
as citrate hydro-lyase. Figure 10 shows that transcription of acnA is regulated by the 
transcription factors Crp, FruR, MarA, Rob, SoxS, ArcA, and Fnr. These transcription 
factors activate or repress the promoter activity of acnAp2 as shown in Figure 11. 
 
 




Figure 11. Promoter and transcription factors for the gene acnA from EcoCyc. 
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The aconitase B enzyme that can also function as citrate hydro-lyase is encoded 
by the gene acnB. Four transcription factors (Crp, ArcA, Fis, and FruR) regulate 
transcription of acnB as illustrated by Figure 12. This gene is transcribed with the help of 
two promoters (acnBp and acnBp2) as shown in Figure 13. However, the transcription 
factors only regulate acnBp so the promoter acnBp2 was not included in the model. 
 
 








Aconitase A is encoded by acnA and can also function as the enzyme isocitrate 
hydro-lyase that catalyzes Reaction 6. See Figure 10 and Figure 11 for the promoter and 
transcription factors involved with acnA. 
The gene acnB encodes for the aconitase B enzyme that can also function as 
isocitrate hydro-lyase. See Figure 12 for the transcription factors regulating acnB and see 
Figure 13 for the promoters involved in the transcription of acnB. 





Isocitrate dehydrogenase catalyzes Reaction 7 and is encoded by the gene icd. 
Transcription factors FruR and ArcA regulate the transcription of icd as illustrated by 
Figure 14. ArcA represses the promoter icdAp1 and FruR activates the promoter icdAp2 
as shown in Figure 15. Both promoters, icdAp1 and icdAp2, were included in the model. 
 
 








The gene sucA encodes for the 2-oxoglutarate decarboxylase subunit of 2-
oxoglutarate dehydrogenase. This enzyme catalyzes Reaction 8 in the model. 
Transcription of sucA is regulated by Crp, Fur, ArcA, Fnr, and IHF as shown in Figure 
16. The promoter sucAp starts the transcription of sucA as illustrated by Figure 17. 
The gene sucB encodes for the second subunit of 2-oxoglutarate dehydrogenase: 
dihydrolipoyltranssuccinylase. The gene sucB is regulated by the same transcription 
factors and promoters as sucA seen in Figure 16 and Figure 17. 
 




Figure 16. Transcription regulation summary diagram for the genes sucA, sucB, sucC, 




Figure 17. Promoter and transcription factors for the genes sucA, sucB, sucC, and sucD 
from EcoCyc. 
 
Lipoamide dehydrogenase is the third subunit of 2-oxoglutarate dehydrogenase 
and is encoded by the gene lpd. This gene is regulated by the transcription factors Fis, 
Crp, Fnr, Fur, ArcA, FruR, and PdhR as shown in Figure 18. The gene lpd has two 
promoters initiating transcription: pdhRp and lpdAp. The promoter pdhRp is affected by 
the transcription factors Crp, Fnr, and PdhR. The promoter lpdAp is regulated by ArcA, 
Crp, Fis, Fnr, and Fur as illustrated in Figure 19. 
 
 
Figure 18. Transcription regulation summary diagram for the gene lpd from EcoCyc. 
 
 








The enzyme succinyl-CoA synthetase is encoded by the genes sucC and sucD. 
This enzyme catalyzes Reaction 9 in the model. These genes are regulated by the same 
transcription factors and promoters as sucA and sucB. Figure 16 shows the transcription 
regulation summary diagram and Figure 17 shows the promoters used to regulate 




The genes sdhA, sdhB, sdhC, and sdhD encode for the enzyme succinate 
dehydrogenase that catalyzes Reaction 10. These four genes are regulated by Crp, Fur, 
ArcA, and Fnr as seen in Figure 20. The promoters sdhCp and sdhDp2 are involved in the 
transcription of these four genes. Figure 21 shows that the promoter sdhCp is regulated 
by ArcA, Crp, Fur, and Fnr while the promoter sdhDp2 is only regulated by Crp. Both 
promoters were included in the model of the transcriptional network. 
 
 
Figure 20. Transcription regulation summary diagram for the genes sdhA, sdhB, sdhC, 
and sdhD from EcoCyc. 










 The gene fumA encodes for the fumarase A enzyme that catalyzes Reaction 11. 
Figure 22 shows the transcription factors that regulate the transcription of fumA. ArcA 
Crp, and Fnr regulate fumA through the promoter fumAp as shown in Figure 23. 
 
 




Figure 23. Promoter and transcription factors for the gene fumA from EcoCyc. 
 
 
 Fumarase B is encoded by the gene fumB and can also catalyze Reaction 11. The 
transcriptional regulation of fumB is more complex than fumA. Figure 24 shows that 
ArcA, Crp, DcuR, Fnr, Fur, Fis, and NarL are all involved in regulating the transcription 
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of fumB. The seven transcription factors regulate the transcription of fumB through three 
promoters shown in Figure 25. Transcription factors ArcA, Fis, Fnr, and Fur are involved 
with the promoter fumBp. Transcription factors Crp, Fnr, and NarL affect the promoter 
dcuBp. The transcription factor DcuR activates promoter activity of dcuBp2. 
 
 




Figure 25. Promoters and transcription factors for the gene fumB from EcoCyc. 
 
The gen fumC encodes for fumarase C that can also catalyze Reaction 11. This 
gene is regulated by seven transcription factors shown in Figure 26: MarA, Rob, SoxR, 
SoxS, ArcA, Fnr, and Fur. These seven transcription factors regulate fumC through the 
promoter fumCp shown in Figure 27. 












Malate dehydrogenase catalyzes Reaction 12 and is encoded in the E. coli genome 
by the gene mdh. The transcription factors Crp, DpiA, ArcA, and FlhCD regulate the 
transcription of mdh as shown in Figure 28. Two promoters, mdhp1 and mdhp2, are 
involved in the transcription of mdh as illustrated by Figure 29. All four transcription 
factors impact mdhp1, whereas only DpiA affects mdhp2. 
 
 
Figure 28. Transcription regulation summary diagram for the gene mdh from EcoCyc. 
 








Isocitrate lyase catalyzes Reaction 13 and is encoded by the gene aceA. The 
transcription factors FruR, IHF, ArcA, Crp, and IclR regulate the transcription of aceA as 
shown by Figure 30. These five transcription factors regulate transcription of aceA 
through their interaction with the promoter aceBp shown in Figure 31. 
 
 














Malate synthase A is the enzyme that catalyzes Reaction 14 and is encoded by the 
gene aceB. The transcription of aceB is under the same regulation as aceA. Figure 30 
shows the five transcription factors and Figure 31 shows the promoter involved in the 
transcription of aceB. 
Malate synthase G can also catalyze Reaction 14. This isozyme is encoded by the 
gene glcB. This gene is regulated by the transcription factors GlcC, IHF, and ArcA as 
shown in Figure 32. There are two promoters involved in the transcription of glcB: glcBp 
and glcDp. Figure 33 shows that only the promoter glcDp is affected by the transcription 
factors; therefore, only glcDp was included in the model. 
 
 








The enzyme glucokinase catalyzes Reaction 15 in the model. This enzyme is 
encoded by the gene glk. The transcription of glk is regulated by the transcription factor 
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FruR as shown in Figure 34. FruR represses the promoter activity of glkp as shown in 
Figure 35. The promoter glkp1 is not affected by transcription factors and was not 
included in the model. 
 
 








The gene pgm encodes the enzyme phosphoglucomutase that catalyzes the first 
step in the reverse direction of Reaction 15. This gene is regulated by HU as shown in 
Figure 36. HU represses the activity of the seqAp promoter as shown in Figure 37. 
 
Figure 36. Transcription regulation summary diagram for the gene pgm from EcoCyc. 
 
 








Glucose-1-phosphatase catalyzes second step in the reverse direction of Reaction 
15. This enzyme is encoded by the gene yihX. Figure 38 and Figure 39 show that no 
transcription factors are known to regulate transcription of yihX. Therefore, this gene was 
not included in the transcriptional network model. 
 
 









Phosphoglucose isomerase catalyzes Reaction 16 and is encoded by the gene pgi. 
Transcription of pgi is regulated by the transcription factor SoxS as shown in Figure 40. 
SoxS interacts with the promoter pgip as shown in Figure 41. 
 
 
Figure 40. Transcription regulation summary diagram for the gene pgi from EcoCyc. 








The gene pfkA encodes for the enzyme 6-phospofructokinase that catalyzes 
Reaction 17. This gene is regulated by the transcription factor FruR as shown in Figure 
42. The promoters pfkAp1 and pfkAp2 initiate transcription of pfkA as seen in Figure 43. 








Figure 43. Promoters and transcription factor for the gene pfkA from EcoCyc. 
 
 
The gene pfkB also encodes for 6-phosphofructokinase. However, as seen in 
Figure 44 and Figure 45, there are no transcription factors associated with the regulation 
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The enzyme fructose-1,6-bisphosphatase that catalyzes the reverse direction of 
Reaction 17 is encoded by the gene glpX. The transcription factors Crp and GlpR regulate 
the transcription of glpX shown in Figure 46. GlpR and Crp regulate the gene by 
interacting with the promoter glpFp shown in Figure 47. 
 
 
Figure 46. Transcription regulation summary diagram for the gene glpX from EcoCyc. 
 
 




Figure 47. Promoter and transcription factors for the gene glpX from EcoCyc. 
 
The gene ybhA also encodes for the enzyme fructose-1,6-bisphosphatase. 
However, as seen in Figure 48 and Figure 49, no transcription factors or promoters are 
known to regulate ybhA. Therefore, the gene ybhA was not included in the model. 
 
 




Figure 49. The gene ybhA from EcoCyc. 
 
 
Another gene, yggF, also encodes for fructose-1,6-bisphosphatase. But, similar to 
the gene ybhA, no transcription factors or promoters have been identified for yggF as 
illustrated by Figure 50 and Figure 51. 
 
 




Figure 51. The gene yggF from EcoCyc. 
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Fructose-1,6-bisphosphatase is encoded by another gene, fbp. Figure 52 and 












Fructose-bisphosphate aldolase is the enzyme that catalyzes Reaction 18 and is 
encoded by the gene fbaA. The transcription factors Crp and FruR regulate the 
transcription of fbaA as shown in Figure 54. Four promoters are known to be associated 
with the transcription of fbaA: epdp, pgkp1, pgkp2, and pgkp3. Figure 55 shows that only 
the promoter epdp is affected by the transcription factors FruR and Crp. Therefore, epdp 
was the only promoter included in the model.  
Fructose-bisphosphate aldolase is also encoded by the gene fbaB. The gene fbaB 
is regulated by the transcription factor FruR as shown in Figure 56. FruR interacts with 
the promoter fbaBp as shown in Figure 57. The promoter fbaBp was included in the 
transcriptional network model for the enzyme fructose-bisphosphate aldolase. 
 
 
Figure 54. Transcription regulation summary diagram for the gene fbaA from EcoCyc. 
 





Figure 55. Promoters and transcription factors for the gene fbaA from EcoCyc. 
 
 




Figure 57. Promoter and transcription factor for the gene fbaB from EcoCyc. 
 
Triose Phosphate Isomerase: 
 
The gene tpiA encodes for the enzyme triose phosphate isomerase that catalyzes 
Reaction 19. The gene tpiA is regulated by the transcription factor FruR as shown in 
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Figure 58. There are two promoters that initiate transcription of tpiA, but only the 
promoter tpiAp2 interacts with transcription factors as illustrated by Figure 59. Therefore, 
only the promoter tpiAp2 was included in the transcriptional network model. 
 
 








The enzyme glyceraldehyde-3-phosphate dehydrogenase catalyzes Reaction 20 
and is encoded by the gene gapA. The transcription factors Crp and FruR regulate the 
transcription of gapA as shown in Figure 60. There are four promoters for the gene gapA 
as shown in Figure 61. Only the promoters gapAp1 and gapAp3 interact with Crp and 
FruR; therefore, only gapAp1 and gapAp3 were included in the model.  
The genes gapC1 and gapC2 also encode for the enzyme glyceraldehyde-3-
phosphate dehydrogenase that catalyzes Reaction 20. The transcription of these two 
genes is regulated by the protein Fnr as shown in Figure 62. Fnr regulates the 
transcription of gapC1 and gapC2 through its interaction with the promoter gapC_1p 
shown in Figure 63. 
 
 

















Figure 63. Promoter and transcription factor for the genes gapC1 and gapC2 from 
EcoCyc. 
 





The gene pgk encodes for the enzyme phosphoglycerate kinase that catalyzes 
Reaction 21. The transcription of pgk is regulated by Crp and FruR as shown in Figure 
64. Four promoters initiate transcription of pgk as shown in Figure 65. Only the promoter 
epdp is regulated; therefore, it was the only promoter included in the model. 
 
 













Phosphoglycerate mutase catalyzes Reaction 22 and is encoded by the gene 
gpmM. This gene is regulated by the transcription factor FruR as shown in Figure 66. 
FruR regulates transcription of gpmM through its interactions with the promoter gpmMp 
as shown in Figure 67. 
 
 




Figure 67. Promoter and transcription factor for the gene gpmM from EcoCyc. 
 
 
The gene ytjC also encodes for the enzyme phosphoglycerate mutase. However, 
as seen in Figure 68 and Figure 69, there are no known promoters and transcription 
factors that regulate ytjC. Therefore, the gene ytjC was not included in the model. 
 
 




Figure 69. The gene ytjC from EcoCyc. 
 
Another gene that encodes for phosphoglycerate mutase is gpmA. The 
transcription of the gene gpmA is regulated by Fur through the promoter gmpAp as 
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illustrated in Figure 70 and Figure 71. Since the second promoter gmpAp2 does not 
interact with transcription factors, only the promoter gmpAp was included in the model. 
 
 








The gene eno encodes for the enzyme enolase that catalyzes Reaction 23 in the 
model. The transcription of eno is regulated by the transcription factor FruR as shown in 
Figure 72. There are nine promoters that have been identified to initiate transcription of 
eno as shown in Figure 73. Out of the nine promoters, only the promoters enop1, enop2, 
and enop3 interact with the transcription factor FruR. Therefore, only the promoters 
enop1, enop2, and enop3 were included in the transcriptional network model. 
 
 
Figure 72. Transcription regulation summary diagram for the gene eno from EcoCyc. 




Figure 73. Promoters and transcription factor for the gene eno from EcoCyc. 
 
 





The enzyme pyruvate kinase catalyzes the forward direction of Reaction 24 and is 
encoded by the gene pykF. The transcription of pykF is regulated by the protein FruR as 
illustrated by Figure 74. The promoters pykFp, pykFp1, pykFp2, and pykFp3 initiate 
transcription of pykF as shown in Figure 75. The only promoter that interacts with FruR 








Figure 75. Promoters and transcription factor for the gene pykF from EcoCyc. 
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Pyruvate kinase is also encoded by the gene pykA. As seen in Figure 76, there are 
no transcription factors known to regulate the transcription of pykA. Two promoters, 
pykAp1 and pykAp2, are known to initiate transcription of pykA as shown in Figure 77. 
Since there are no transcription factors involved, the gene pykA was not included in the 
transcriptional network model. 
 
 








The gene ppsA encodes for the enzyme phosphoenolpyruvate synthetase that 
catalyzes the reverse direction of Reaction 24. Figure 78 shows that FruR is the only 
transcription factor that regulates ppsA. FruR interacts with the promoter ppsp as 
illustrated by Figure 79. 
 
 
Figure 78. Transcription regulation summary diagram for the gene ppsA from EcoCyc. 
 
 








The gene pck encodes for the enzyme phosphoenolpyruvate carboxykinase that 
catalyzes Reaction 25. Transcription of the gene pck is regulated by the protein FruR as 
shown in Figure 80. FruR regulates transcription by interacting with the promoter pckp as 
shown in Figure 81. 
 
 








The enzyme pyruvate dehydrogenase is a complex composed of three subunits. 
The first subunit is encoded by the gene aceE. Figure 82 shows that transcription of aceE 
is regulated by the proteins Crp, Fnr, ArcA, FruR, NsrR, and PdhR. The pdhRp and 
aceEp promoters interact with these transcription factors as illustrated by Figure 83. Both 
pdhRp and aceEp were included in the model. 
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The second subunit of pyruvate dehydrogenase is encoded by the gene aceF. The 
gene aceF is in the same operon as the gene aceE. See Figure 82 and Figure 83 for the 
transcription factors and promoters that regulate transcription of aceF. 
 The gene lpd codes for the third subunit of pyruvate dehydrogenase that is 
also a subunit of the enzyme 2-oxoglutarate dehydrogenase. See Figure 18 and Figure 19 
for the transcription factors and promoters that regulate lpd. 
 
 





Figure 83. Promoters and transcription factors for the genes aceE and aceF from EcoCyc. 
 
Transcription Regulatory Proteins 
Transcription regulatory proteins are proteins that have a DNA binding domain 
and regulate the transcription of genes. When the DNA binding domain is accessible, 
these proteins bind to the DNA near promoters. If the regulatory protein is a repressor, it 
interferes with the ability of the RNA polymerase to bind to the promoter and initiate 
  79 
 
 
transcription. If the protein is an activator, it increases the binding affinity between RNA 
polymerase and the promoter in order to upregulate transcription of a gene (Lehninger et 
al, 2008). 
Transcription factors can be turned off or on through ligand binding. Ligand 
binding induces a conformational shift that can either open or close the DNA binding 
domain of the protein (Lehninger et al, 2008). In order to correctly model the 
transcriptional network, it was important to understand when and how the regulatory 
proteins became active transcription factors. This section explains the interactions with 
ligands and the specific regulatory proteins identified in this model. A summary chart of 




ArcA is a transcriptional regulatory protein that is capable of binding to DNA 
when phosphorylated by the kinase ArcB. Phosphorylated ArcA acts as a repressor by 
binding to promoters or activator binding sites (Jeon et al, 2001). ArcA-P is a 
transcriptional repressor for many of the TCA cycle and glyoxylate enzymes under 
anaerobic conditions (Gunsalus & Park, 1994). ArcA acts as a transcriptional activator 





The Crp transcriptional regulator, also known as CAP, can bind to DNA only 
when activated by cAMP. In the absence of glucose, cAMP-Crp levels rise allowing 
more Crp to bind to DNA (Ishizuka et al, 1994). Crp generally acts as a transcriptional 
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activator by binding upstream of the polymerase binding site. However, it can also act as 
a repressor by occupying the binding site of an activator protein or by interfering with the 




The DcuR regulatory protein is activated for DNA binding through 
phosphorylation by kinase DcuS. Upon phosphorylation of an aspartate residue, DcuR 




DpiA is a transcriptional regulator that can bind to DNA when phosphorylated on 
an aspartate residue. It binds to DNA sequences rich in A and T nucleotides. DpiA-P is a 
transcriptional activator of malate dehydrogenase when citrate is available in an 




Fis is a small protein capable of tight binding to DNA when dimerized (Finkel & 
Johnson, 1992). One study indicated that approximately 21% of genes are regulated by 




FlhD and FlhC are proteins that can form the heterotetramer FlhD2C2. As a 
heterotetramer, FlhDC can bind to DNA and act as a transcriptional repressor or 
activator. No inducer has been observed for FlhDC (Stafford et al, 2005). 
 
 





Fnr is a protein that activates genes needed for anaerobic metabolism and 
represses genes used for aerobic metabolism. The concentration of Fnr remains 
approximately the same under aerobic and anaerobic conditions (~3.7 µM) (Sutton et al, 
2004). The DNA-binding activity of Fnr is regulated by oxygen. In the absence of 
oxygen, a [4Fe-4S] cluster binds to Fnr allowing the protein to dimerize. As a dimer, Fnr 
can bind to DNA and activate or repress transcription. In the presence of oxygen, the 




FruR is a transcriptional regulator also known as Cra. Unmodified FruR can bind 
to DNA and can activate transcription of genes in the TCA cycle, the glyoxylate 
pathways, and gluconeogenesis. FruR acts as a repressor for genes involved in glycolysis. 
Fructose-1,6-bisphosphate and fructose-1-phosphate can bind with FruR and prevent 




Fur is a transcriptional activator and repressor that can only bind to DNA with the 
cofactor Fe
2+
. Fur is a regulator of many genes including some involved in the TCA 




GlcC is a dual transcriptional regulator that can bind to DNA when induced by 
glycolate. It regulates genes needed when glycolate is the main carbon source (Pellicer et 
al, 1999). 





GlpR is a transcriptional repressor that can bind to DNA in its unmodified form. 
Binding of either glycerol or glycerol-3-phosphate to GlpR causes a conformational shift 




Histone-like nucleoid structuring protein (H-NS) is a small DNA-binding protein 
used to condense and supercoil DNA. It acts as a transcription factor for several genes, 




HU is a transcriptional dual regulator. It is a small DNA-binding protein similar to 
histones and helps supercoil DNA. It can bind to DNA and act as a transcriptional 




IclR is a transcriptional repressor that regulates enzymes in the glyoxylate shunt. 
Pyruvate and glyoxylate can bind to IclR. Pyruvate stabilizes the active tetrameric form 
that can bind to DNA while glyoxylate stabilizes the inactive dimer form that cannot bind 




IHF is a protein that is highly abundant in cells, and is used as both a 
transcriptional repressor and activator. IHF often stabilizes correct nucleoprotein 
complexes and can facilitate the formation of loops near the promoter. It is a heterodimer 
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protein that binds to A/T rich sequences of DNA. IHF requires no inducer to bind to 




LacI is an inducible transcriptional repressor for the lac operon. Unmodified LacI 
can bind to DNA at two operators forming a repressor loop to reduce transcription. 
Allolactose, or IPTG, can bind to LacI and cause a conformational shift that prevents 




MarA is a dual transcriptional regulator similar to SoxS and Rob. MarA binds to a 
specific DNA sequence known as the sox-mar-rob box. MarA requires no inducer to bind 




NarL is a nitrate/nitrite response regulator that can activate and repress 
transcription of genes needed for nitrate respiration and other pathways. In the presence 
of nitrate or nitrite, the kinase NarX phosphorylates NarL. Phosphorylated NarL is 
capable of binding to DNA. In the absence of nitrate and nitrite, NarL is inactivated by 




NsrR is a nitrate-sensitive repressor that regulates at least 30 genes. NsrR can only 
bind to DNA with the cofactor [2Fe-2S] cluster. If nitric oxide (NO) binds to the [2Fe-
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2S] cluster, then NsrR can no longer bind to DNA (Tucker et al, 2008). Ammonium 




PdhR is a transcriptional repressor for genes coding the pyruvate dehydrogenase 
and 2-oxoglutarate dehydrogenase complexes. Unmodified PdhR can bind to DNA to 
repress transcription. Pyruvate can bind to PdhR and cause a conformational shift that 




Rob is a transcriptional activator similar to SoxS and MarA and binds to the sox-




SoxR is a transcriptional activator that is activated by the cofactor [2Fe-2S] 
cluster. SoxR can bind to DNA with or without [2Fe-2S], but is only able to activate 




SoxS is a transcriptional activator sensitive to superoxide and nitric oxide. SoxS is 
similar to Rob and MarA and binds to the sox-mar-rob box DNA sequence (Martin et al, 
2008). Activity of SoxS is controlled solely by its concentration (Griffith et al, 2004). 
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Transcriptional Network Equations 
The metabolic pathways modeled consist of many enzymatic reactions. These 
enzymatic reactions are intrinsically dependent upon the concentration of the enzymes. 
The concentration of enzymes in a cell is dependent upon the quantity being transcribed 
and translated from the DNA coupled with the rate of enzyme degradation. Expressions 
were used to relate enzyme concentration to promoter activity and transcription factors. 
The concentration of transcription factors was related to the frequency of ligand binding. 
Enzyme degradation was correlated to the amino acid on the N-terminus of the enzyme’s 
polypeptide. The following equations were used to model the concentration of enzymes 




An equation was needed to correlate the amount of enzyme synthesized to its 
transcription factors and promoters. Equation (11) describes enzyme concentration as a 
function of the concentration of a single transcription factor (Ronen et al, 2002; Zaslaver 











             (11) 
 E = Enzyme concentration 
 β = Promoter activity (unrepressed/inactivated) 
 TF = Transcription factor concentration 
 k = Effective affinity of the transcription factor 
   (Conc. for half maximal repression/activation) 
 H = Hill coefficient of cooperativity 
    H > 0 = repression 
    H < 0 = activation 
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Equation (11) was modified as part of this thesis development to include terms for 
multiple transcription factors affecting one promoter. Equation (12) was the result and it 
relates enzyme concentration to the concentrations of n transcription factors. This 
equation calculates the enzyme concentration based on all of the activators and repressors 
















   (




              (12) 
  
 E = Enzyme concentration 
 β = Promoter activity (unrepressed/inactivated) 
 TFn = Transcription factor n concentration 
 kn = Effective affinity of transcription factor n 
   (Conc. for half maximal repression/activation) 
 Hn = Hill coefficient of cooperativity 
    H > 0 = repression 
    H < 0 = activation 
 
 
Each promoter found to be regulated by transcription factors was represented by a 
reaction as shown in Figure 84. The rate for each promoter reaction was based on 
Equation (12). Forty promoters were used to model the transcription of 29 enzymes as 
seen in Figure 84. The transcription factors that regulate each promoter are shown as 
substrates to the promoter reactions, with enzymes shown as products of the reaction. 
Eight of the promoters initiate transcription of more than one enzyme, so multiple 
enzymes are shown as products of those reactions. Thirteen of the enzymes are impacted 
by multiple promoters, so they are shown as products of multiple promoter reactions. 
Table XXVII contains values from the literature that were used for the transcription 
factor terms in Equation (12) for each promoter reaction.  
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Figure 84. SimBiology model diagram of enzyme and transcription factor interactions. 
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Table XXVII. Transcription factor concentrations [TF] and effective affinity values (kn). 
TF [TF] µM kn Organism Reference 
ArcA NA 0.25-0.6 E. coli Shen & Gunsalus, 1997 
Crp  3.3-9.4 NA E. coli Ishizuka et al, 1993 
DcuR 0.7-1.7 6 E. coli Abo-Amer et al, 2004 
Fis 0.17
 
NA E. coli Azam et al, 1999  
Fnr 3.7 NA E. coli Sutton et al, 2004 
Fur 8.3-16.6 NA E. coli Zheng et al, 1999 
H-NS 13
 
NA E. coli Azam et al, 1999   
HU 50 NA E. coli Azam et al, 1999   
IHF 42 NA E. coli Azam et al, 1999   
LacI 0.033 NA E. coli Zheng et al, 1999 
MarA 0.067 0.02 E. coli Martin et al, 1996 
NarL NA 0.9-1.4 E. coli Darwin et al, 1997 
NsrR NA 0.02 N. gonorrhoeae Isabella et al, 2009 
PdhR 0.61 0.005 E. coli Quail & Guest, 1995 
Rob 17
 
NA E. coli Azam et al, 1999 
SoxR 0.17 0.045 E. coli Hidalgo & Demple, 1994 
Pomposiello & Demple, 2001  
SoxS 0.2 0.015 E. coli Li & Demple, 1994 
Martin et al, 1996 
Active Transcription Factor Concentration: 
 
Transcription factors are proteins with DNA binding domains that allow the 
protein to regulate transcription of certain genes. The DNA binding domain can be made 
more or less accessible by the binding of ligands to the transcription factor. The 
concentration of active transcription factor is the amount of the transcription factor that 
has the DNA binding domain accessible. Equation (13) shows how the fraction of 




[ ]   
               (13) 
 
 L = Ligand concentration 
 Kd = Dissociation constant 
 θ = Fraction of binding sites bound with ligand 
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The transcription factors FruR, GlpR, PdhR, LacI, and IclR have DNA binding 
domains that are made less accessible when a specific ligand binds to the transcription 
factor. For these transcription factors, Equation (14) was used to calculate the active 
transcription factor concentration in the model. In the model, Equations (13) and (14) 
were entered as Rules to calculate the active concentration of FruR, GlpR, PdhR, LacI, 
and IclR at each time step. 
 
 TFA = (1-θ)*[TF] (14) 
 
 TFA  =  Active transcription factor concentration 
 θ = Fraction of binding sites bound with ligand 
 TF  =  Total transcription factor concentration 
 
 
ArcA, CRP, DcuR, DpiA, Fnr, Fur, GlcC, IclR, NarL, NsrR, and SoxR are 
transcription factors that need a specific ligand bound in order to open up the DNA 
binding domain. Equations (13) and (15) were used to calculate the active transcription 
factor concentration in the model for transcription factors that require ligand-binding. 
Rules were used to evaluate the two equations at each time step for these 11 transcription 
factors. 
 
 TFA = θ*[TF] (15) 
 
 TFA  =  Active transcription factor concentration 
 θ = Fraction of binding sites bound with ligand 
 TF  =  Total transcription factor concentration 
 
 
The DNA binding domains have not yet been found to be affected by ligand-
binding for the transcription factors Fis, FlhDC, H-NS, HU, IHF, MarA, Rob, and SoxS. 
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The active transcription factor concentration was set equal to the total transcription factor 
concentration for these regulatory proteins. Table XXVIII shows values found in the 
literature for ligand concentrations that were used in the model. The model diagram for 
the interactions between transcription factors and ligands is shown in Figure 85. 
 
Table XXVIII. Known values for ligand concentrations used in the model. 






Makman & Sutherland, 1965 
Krishna et al, 2009 
Glycerol 4200 S. cerevisiae Hynne et al, 2001 










Nazaret et al, 2009 
Helfert et al, 2001 
Teusink et al, 2000 
Nielsen et al, 1998 
 
 
Figure 85. SimBiology model diagram of ligand and transcription factor interactions. 




The intracellular concentration of an enzyme is dependent upon the amount 
synthesized and degraded. Enzyme synthesis is represented in this model by the 
transcriptional network. Degradation reactions were added to the model to prevent 
constant accumulation of enzyme concentrations. 
Degradation reactions were modeled using simple-mass action kinetics with the 
rate constant calculated from the enzyme half-life as shown in Equation (16). Enzyme 
half-lives were estimated based on the N-end rule (Varshavsky, 1997). Enzyme half-lives 
have a rough correlation with the amino acid on the N-terminus of the polypeptide chain.  
 
   




 r  =  Degradation rate 
 τ = Enzyme half-life 
 
 
 The N-terminal amino acid was determined for each enzyme and the degradation 
rate was calculated from the half-life determined from the N-end rule. Figure 86 shows 
the model diagram for the enzyme degradation reactions. Because degradation rates are 
only estimates, these values were adjusted later on to achieve the best fit to published 
models. 
 




Figure 86. SimBiology model diagram of enzyme degradation reactions. 
  





Metabolic profiling is the process of monitoring the concentration of specific 
metabolites over time. The resulting data can be used to adjust parameters in order to 
create a more accurate model of the metabolic pathways in a specific strain of bacteria. 
Metabolic profiling requires culture samples to be quenched at specific time intervals. 
Quenching provides metabolic concentrations at a given time. One of the most common 
quenching methods is to shock the samples with a cold-buffered aqueous methanol 
mixture (Bajad et al, 2006; Buchholz et al, 2001; Dettmer et al, 2006; Lu et al, 2008; 
Mashego et al, 2007; Ohashi et al, 2007). 
After sample preparations, metabolite concentrations can be determined through 
combinations of liquid chromatography (LC), gas chromatography (GC), mass 
spectrometry (MS), capillary electrophoresis (CE), and nuclear magnetic resonance 
(NMR) (Bajad et al, 2006; Buchholz et al, 2001; Dettmer et al, 2006; Lu et al, 2008; 
Mashego et al, 2007; Ohashi et al, 2007). Liquid chromatography combined with mass 
spectrometry (LC-MS) is effective because it can use a small sample volume to 
determine the concentrations of many metabolites simultaneously. One study was able to 
analyze the concentration of 69 metabolites from a single sample (Bajad et al, 2006). 
The data obtained from metabolic profiling can be incorporated into the predictive 
model to allow a more precise simulation of the metabolic pathways under analysis. 
Metabolic profiling can continue to be used in the iterative process of genetically 
engineering an optimized PHB producing strain of bacteria. 




Materials and Methods 
Strains and Culture Methods: 
E. coli XL1-Blue cells containing the pBHR68 plasmid have been shown to 
accumulate as much as 55% of their cell dry weight as bio-plastic (Linton, 2010). 
Analysis of the metabolomics was conducted on samples from this cell line and a control 
study was performed using untransformed E. coli XL1-Blue cells. The control study used 
the same procedures outlined below with the exception of adding ampicillin to the growth 
media. 
Cells were pre-cultured by inoculating 5 mL of M9 growth media with 50 µL of a 
frozen glycerol stock. The M9 growth media was supplemented with 50 µg/mL 
ampicillin for selection of cells harboring the pBHR68 plasmid. Cultures were grown for 
10 hours and then used to inoculate a second culture in 5 mL of M9 growth media (1:100 
v/v). The second culture was grown for 10 hours and then used to inoculate a third 
culture in 5 mL of M9 growth media (1:100 v/v). The third culture was grown for 10 
hours and then used to inoculate 150 mL M9 growth media (1:100 v/v) containing 1% 
(w/v) glucose and 50 µg/mL ampicillin. Cells were grown to stationary phase, and then 
isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to a final concentration of 0.1 
mM. Additional glucose, 15 mL of 7.5% (w/v) glucose solution, was added 5 hours after 
inoculation. Starting 5 hours after inoculation, 0.5 mL samples were taken every 15 
minutes until cell growth reached stationary phase. Absorbance of the cultures was 
recorded at 600 nm every 30 minutes to monitor cell growth. 
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Quenching and Sample Preparation: 
The samples were quenched for metabolic activity by adding 2.5 mL of -50
o 
C 
aqueous methanol (60% v/v) containing 70 mM Hepes buffer (Bajad et al, 2006). 
Samples were sonicated for 2 minutes while kept on ice in order to lyse the cells. 
Samples were lyophilized using a speed vacuum and then re-suspended in 300 µL of 
quenching fluid in order to concentrate the samples. Then the samples were centrifuged 
for 10 minutes at 10,286g. Cell pellets were discarded and then the supernatant was 
stored at -80
o 
C. All samples were stored for future analysis by high performance liquid 
chromatography and mass spectrometry (HPLC-MS). Recommended analytical methods 
for HPLC-MS are outlined in Appendix B. 
 
Results 
Growth curves obtained from the optical density for the two strains of E. coli are 
shown in Figure 87. After IPTG was added, the strain with the pBHR68 plasmid showed 
slower cell growth than the other strain as seen in Figure 87. Slower cell growth after 
induction by IPTG is consistent with the hypothesis that energy is being diverged from 
normal cellular functions in order to synthesize PHB. 
Metabolic profiling data was not obtained due to the unavailability of a 
functioning mass-spectrometer. Metabolic profiling samples were stored at -80
o
 C for 
future analysis. It was anticipated that the metabolic profiling data would be used to 
better fit the predictive model to the specific strain of E. coli under study. Because this 
data was unavailable, the model was fit to nine published models and to preliminary PHB 
production data as shown in the next chapter. 






Figure 87. Natural log of the absorbance at time t divided by (A) the initial absorbance 
reading and (B) absorbance reading at t = 5 hr plotted over time. Absorbance was read at 
600 nm. At t = 5 hr, 15 mL of 5 x glucose solution was added to both cultures and IPTG 
was added to a final concentration of 0.1 mM in the XL1-Blue + pBHR68 culture. Error 
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SIMULATIONS AND RESULTS 
Comparing Model with Literature 
The glycolysis and TCA portions of the SimBiology model were validated using 
published models found in the BioModels database at http://www.ebi.ac.uk/biomodels-
main/publ-models.do. This database is a compilation of published models assembled by 
the European Bioinformatics Institute. Out of 366 curated BioModels, seven were 
identified as glycolysis models and two were identified as TCA cycle models. These nine 




Seven BioModels including 42, 61, 64, 71, 172, 176, and 177 were used to 
validate the glycolysis portion of the predictive model. The online simulator in the 
BioModels database was used to run simulations of the species in glycolysis. The 
SimBiology model was adjusted to match its steady-state concentrations with the steady-
state concentrations of the glycolysis intermediates simulated in the BioModels. The first 
two BioModels (42 and 61) modeled glycolytic oscillations observed in synchronous 
cultures. The SimBiology model is not a model for synchronous cultures; therefore, the 
SimBiology model was adjusted to match the average steady-state concentrations of the 
glycolysis species for these two BioModels. 
The SimBiology model needed to be altered to accurately match these seven 
BioModels. The BioModels do not account for PHB synthesis; therefore, the PHB 
synthesis pathway was shut off in the model by inactivating the forward and reverse 
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directions of Reaction 1. To account for diffusion of extracellular glucose into the cell, 
Reaction 0 was created using simple mass action kinetics. Reaction 27 was added to 
account for pyruvate used elsewhere in the cell and Reaction 28 was created to account 
for acetyl-CoA used in pathways not included in the model. Reactions 27 and 28 were 
modeled using simple mass action kinetics. 
None of the BioModels accounted for the transcriptional network. Therefore, the 
transcriptional network portion of the SimBiology model was inactivated by holding the 
enzyme concentrations constant. All of the seven BioModels identified above simulated 
continuous cultures, so the concentration of extracellular glucose was held constant in the 
predictive model. The concentrations of ATP, ADP, NAD
+
, and NADH were also held 
constant during simulation. Initial concentrations of glycolysis substrates were changed 
to match the initial values used in each BioModel. The value zero was used for any initial 
concentration not specified in the BioModel. The values for Reaction 0, Reaction 27, 
Reaction 28, and the glycolysis enzyme concentrations were adjusted until the 
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BioModel 42 - Nielsen 1998 Glycolysis: 
 
BioModel 42 is a glycolysis model for S. cerevisiae (Nielsen et al, 1998). This 
model simulates observed oscillations in a continuous-flow, stirred tank reactor. 
Glycolytic oscillations in yeast are a result of a synchronous culture. BioModel 42 used 
the initial concentrations shown in Table XXIX. In order to fit the SimBiology model to 
BioModel 42, the values in Table XXIX were used as initial concentrations in the 
SimBiology model. 
Twelve variables were adjusted in order to match the simulations between the 
SimBiology model and BioModel 42. Two of the variables were reaction rates for 
Reaction 0 and Reaction 27. The other ten variables were the glycolysis enzyme 
concentrations. Table XXIX shows the enzyme concentrations and reaction rates used to 
successfully fit the model. Figure 88 and Figure 89 visually compare the simulations 
from BioModel 42 with the adjusted SimBiology model. 
 
 
Figure 88. Simulations from (A) BioModel 42 and (B) SimBiology model for the species 








Figure 89. Simulations from (A) BioModel 42 and (B) SimBiology model for the species 
glyceraldehyde-3-phosphate, phosphoenolpyruvate, and pyruvate. 
 
 
Table XXIX. Initial substrate concentrations, enzyme concentrations, and reaction rates 
used to compare the SimBiology model to BioModel 42. 





GLC_ex 6000 µM Nielsen et al, 1998 
GLC 11.3 µM Nielsen et al, 1998 
G6P 0 µM ---- 
F6P 659 µM Nielsen et al, 1998 
FBP 7.7 µM Nielsen et al, 1998 
GAP 1.9 µM Nielsen et al, 1998 
DHAP 0 µM ---- 
DPG 299 µM Nielsen et al, 1998 
3PG 0 µM ---- 
2PG 0 µM ---- 
PEP 2.1 µM Nielsen et al, 1998 
PYR 4.2 µM Nielsen et al, 1998 
Enzyme 
Concentrations 
Used to Fit Model 
KIN 310 µM ---- 
PGI 50 µM ---- 
6PFK 0.8328 µM ---- 
FBA 880.33 µM ---- 
TPI 0.56 µM ---- 
GAD 351.7 µM ---- 
PGK 6.65045 µM ---- 
PGM 2.06 µM ---- 
ENO 420 µM ---- 
PYK 2.52 µM ---- 
Reaction Rates 
Used to Fit Model 
R0 0.01 µM/s ---- 
R27 1.17 µM/s ---- 
A B 
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BioModel 61 - Hynne 2001 Glycolysis: 
 
BioModel 61 is another model for glycolysis in S. cerevisiae (Hynne et al, 2001). 
Similar to BioModel 42, this model simulates glycolytic oscillations in yeast. BioModel 
61 used the initial species concentrations found in Table XXX. The values in Table XXX 
were used as initial substrate concentrations to fit the SimBiology model to BioModel 61 
Many different values for ten enzymes and two reaction rates were tried in order 
to successfully fit the model to BioModel 61. Table XXX shows the combination of 
values that resulted in a successful fit to BioModel 61. The matching simulations between 
the model and BioModel 61 are shown in Figure 90, Figure 91, and Figure 92.   
BioModel 61 did not have simulations available for the species 2-
phosphoglycerate and 3-phosphoglycerate. The average simulation value from the other 
BioModels for 2-phosphoglycerate was 0.062 mM. The average simulation value for 3-
phosphoglycerate was 0.48 mM. For these two species, the SimBiology model was fit to 
match the average values as shown in Figure 93. 
 
 
Figure 90. Simulations from (A) BioModel 61 and (B) SimBiology model for the species 
glucose intracellular, glucose extracellular, and pyruvate. 
A B 




Figure 91. Simulations from (A) BioModel 61 and (B) SimBiology model for the species 





 Figure 92. Simulations from (A) BioModel 61 and (B) SimBiology model for the species 
1,3-diphosphoglycerate, glyceraldehyde-3-phosphate, and phosphoenolpyruvate. 
 
BioModel 64 – Teusink 2000 Glycolysis: 
 
BioModel 64 is another glycolysis model for S. cerevisiae (Teusink et al, 2000). 
This model simulates steady-state fluxes in a continuous fed reactor. Unlike BioModel 42 
and 61, this BioModel does not model glycolytic oscillations. The initial species 
concentrations in Table XXXI were used in BioModel 64 and in the SimBiology model. 
A B 
A B 




Figure 93. Simulation from SimBiology model for the species 2-phosphoglycerate and 3-
phosphoglycerate. BioModel 61 had no simulations for these species.   
 
 
Table XXX. Initial substrate concentrations, enzyme concentrations, and reaction rates 
used to compare the SimBiology model to BioModel 61. 





GLC_ex 24000 µM Hynne et al, 2001 
GLC 573 µM Hynne et al, 2001 
G6P 4200 µM Hynne et al, 2001 
F6P 490 µM Hynne et al, 2001 
FBP 4640 µM Hynne et al, 2001 
GAP 115 µM Hynne et al, 2001 
DHAP 2950 µM Hynne et al, 2001 
DPG 0.27 µM Hynne et al, 2001 
3PG 0 µM ---- 
2PG 0 µM ---- 
PEP 40 µM Hynne et al, 2001 
PYR 8700 µM Hynne et al, 2001 
Enzyme 
Concentrations 
Used to Fit Model 
KIN 310 µM ---- 
PGI 50 µM ---- 
6PFK 4.0 µM ---- 
FBA 3585 µM ---- 
TPI 0.56 µM ---- 
GAD 1427 µM ---- 
PGK 150 µM ---- 
PGM 2.06 µM ---- 
ENO 420 µM ---- 
PYK 9.0 µM ---- 
Reaction Rates 
Used to Fit Model 
R0 0.01 µM/s ---- 
R27 0.022 µM/s ---- 
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Different combinations of enzyme concentrations and reaction rate values were 
simulated in the SimBiology model. The values found in Table XXXI were a successful 
combination that resulted in a good fit to BioModel 64. Figure 94 and Figure 95 show 
how closely the SimBiology model simulations matched the BioModel 64 simulations. 
BioModel 64 had no simulations available for glyceraldehyde-3-phosphate and 
dihydroxyacetone phosphate. The average concentration for glyceraldehyde-3-phosphate 
from other BioModels was 2.14 mM. The average concentration for dihydroxyacetone 
phosphate from BioModels 71, 172, 176, and 177 was 0.032 mM. The SimBiology model 
was adjusted to match these average values as shown in Figure 96. 
 
 
 Figure 94. Simulations from (A) BioModel 64 and (B) SimBiology model for the species 
3-phosphoglycerate, fructose-1,6-bisphosphate, glucose-6-phosphate, and pyruvate. 
 
BioModel 71 - Bakker 2001 Glycolysis: 
 
BioModel 71 simulates glycolysis in the protist species T. brucei (Helfert et al, 
2001). Like the other glycolysis BioModels, this one also models a continuous fed 
reactor. Initial substrate concentrations in the SimBiology model were set to match the 
initial concentrations in BioModel 71 shown in Table XXXII.  
A B 




Figure 95. Simulations from BioModel 64 for the species 1,3-diphosphoglycerate, 2-
phosphoglycerate, fructose-6-phosphate, glucose intracellular, and phosphoenolpyruvate. 
 
 
Table XXXI. Initial substrate concentrations, enzyme concentrations, and reaction rates 
used to compare the SimBiology model to BioModel 64. 





GLC_ex 50000 µM Teusink et al, 2000 
GLC 87 µM Teusink et al, 2000 
G6P 2450 µM Teusink et al, 2000 
F6P 620 µM Teusink et al, 2000 
FBP 5510 µM Teusink et al, 2000 
GAP 0 µM ---- 
DHAP 0 µM ---- 
DPG 0 µM ---- 
3PG 900 µM Teusink et al, 2000 
2PG 120 µM Teusink et al, 2000 
PEP 70 µM Teusink et al, 2000 
PYR 1850 µM Teusink et al, 2000 
Enzyme 
Concentrations 
Used to Fit Model 
KIN 354 µM ---- 
PGI 14.22 µM ---- 
6PFK 1.05 µM ---- 
FBA 790 µM ---- 
TPI 0.11 µM ---- 
GAD 250 µM ---- 
PGK 34 µM ---- 
PGM 0.377 µM ---- 
ENO 86.0 µM ---- 
PYK 1.245 µM ---- 
Reaction Rates 
Used to Fit Model 
R0 0.0008 µM/s ---- 
R27 0.00799 µM/s ---- 
 
A B 




Figure 96. Simulation from SimBiology model for the species glyceraldehyde-3-




The values of the glycolysis enzymes and the reaction rates of Reaction 0 and 
Reaction 27 were adjusted to fit the model to BioModel 71. The values that resulted in a 
successful fit are found in Table XXXII.  The best fit was determined by comparing each 
glycolysis substrate simulation between BioModel 71 and the SimBiology model. Figure 
97, Figure 98, and Figure 99 show how the simulations of BioModel 71 compare with the 
simulations of the SimBiology model.  
 
 
Figure 97. Simulations from (A) BioModel 71 and (B) SimBiology model for the species 
dihydroxyacetone phosphate, fructose-1,6-bisphosphate, glucose-6-phosphate, 
extracellular glucose, and pyruvate. 
A B 
  107 
 
 
Table XXXII. Initial substrate concentrations, enzyme concentrations, and reaction rates 
used to compare the SimBiology model to BioModel 71. 





GLC_ex 50000 µM Helfert et al, 2001 
GLC 34 µM Helfert et al, 2001 
G6P 2072 µM Helfert et al, 2001 
F6P 512 µM Helfert et al, 2001 
FBP 16537 µM Helfert et al, 2001 
GAP 39.9 µM Helfert et al, 2001 
DHAP 3899 µM Helfert et al, 2001 
DPG 32.7 µM Helfert et al, 2001 
3PG 0 µM ---- 
2PG 0 µM ---- 
PEP 0 µM Helfert et al, 2001 
PYR 4774 µM Helfert et al, 2001 
Enzyme 
Concentrations 
Used to Fit Model 
KIN 1200 µM ---- 
PGI 78.5 µM ---- 
6PFK 0.805 µM ---- 
FBA 724.23 µM ---- 
TPI 0.1059 µM ---- 
GAD 309.5 µM ---- 
PGK 5.919 µM ---- 
PGM 0.3977 µM ---- 
ENO 87.1 µM ---- 
PYK 1.2015 µM ---- 
Reaction Rates 
Used to Fit Model 
R0 0.01 µM/s ---- 




Figure 98. Simulations from (A) BioModel 71 and (B) SimBiology model for the species 
3-phosphoglycerate, fructose-6-phosphate, and phosphoenolpyruvate. 
 
A B 




Figure 99.  Simulations from (A) BioModel 71 and (B) SimBiology model for the species 
1,3-diphosphoglycerate, intracellular glucose, and glyceraldehyde-3-phosphate. 
 
 
BioModel 71 had no simulation available for 2-phosphoglycerate. The 
SimBiology simulation of 2-phosphoglycerate was fitted to the average concentration 
from the other BioModels. Figure 100 shows how the simulation matches the average 
value of 0.62 mM for 2-phosphoglycerate. 
 
 
Figure 100. Simulation from SimBiology model for the species 2-phosphoglycerate. 
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BioModel 172 - Pritchard 2002 Glycolysis: 
 
BioModel 172 is a model of S. cerevisiae glycolysis (Pritchard & Kell, 2002). 
Similar to BioModel 64, this model does not simulate glycolytic oscillations in yeast. 
BioModel 172 is a model for a continuous fed reactor. Initial species concentrations used 
in BioModel 172 were also used in the SimBiology model and are shown in Table 
XXXIII. Enzyme concentrations and reaction rates were varied in the SimBiology model 
in order to find a successful fit to BioModel 172. The best fit came from the values in 
Table XXXIII. 
Comparison of species simulations between BioModel 172 and the SimBiology 
model are shown in Figure 101, Figure 102, and Figure 103. These figures show closely 
matched simulations for all 11 glycolysis species that BioModel 172 can simulate. 
 
 
Figure 101. Simulations from (A) BioModel 172 and (B) SimBiology model for the 








Figure 102. Simulations from (A) BioModel 172 and (B) SimBiology model for the 





Figure 103. Simulations from (A) BioModel 172 and (B) SimBiology model for the 
species glyceraldehyde-3-phosphate, 1,3-diphosphoglycerate, and phosphoenolpyruvate. 
 
 
BioModel 172 had no simulation available for dihydroxyacetone phosphate. The 
simulation for dihydroxyacetone phosphate in the SimBiology model was matched to an 
average concentration from other BioModels. BioModels 176 and 177 had an average 
concentration of 0.785 mM for dihydroxyacetone phosphate. Figure 104 shows the 
SimBiology simulation of dihydroxyacetone phosphate to be close to this value. 
A B 
A B 
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Table XXXIII. Initial substrate concentrations, enzyme concentrations, and reaction rates 
used to compare the SimBiology model to BioModel 172. 





GLC_ex 2000 µM Pritchard & Kell, 2002 
GLC 97.7 µM Pritchard & Kell, 2002 
G6P 2675 µM Pritchard & Kell, 2002 
F6P 625 µM Pritchard & Kell, 2002 
FBP 6221 µM Pritchard & Kell, 2002 
GAP 45.2 µM Pritchard & Kell, 2002 
DHAP 0 µM ---- 
DPG 0.74 µM Pritchard & Kell, 2002 
3PG 886 µM Pritchard & Kell, 2002 
2PG 128 µM Pritchard & Kell, 2002 
PEP 63 µM Pritchard & Kell, 2002 
PYR 1815 µM Pritchard & Kell, 2002 
Enzyme 
Concentrations  
Used to Fit Model 
KIN 207.4 µM ---- 
PGI 40.0 µM ---- 
6PFK 0.835 µM ---- 
FBA 417.2 µM ---- 
TPI 0.105 µM ---- 
GAD 133.4 µM ---- 
PGK 63.9 µM ---- 
PGM 0.241 µM ---- 
ENO 58.0 µM ---- 
PYK 1.11 µM ---- 
Reaction Rates 
Used to Fit Model 
R0 0.01 µM/s ---- 
R27 0.0242 µM/s ---- 
 
 
Figure 104. Simulation from SimBiology model for the species dihydroxyacetone 
phosphate. BioModel 172 had no simulations available for this species. 
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 BioModel 176 - Conant 2007 WGD Glycolysis 2A3AB: 
 
BioModel 176 is also a simulation of glycolysis in the species S. cerevisiae 
(Conant & Wolfe, 2007). This BioModel is based on a continuous fed reactor and does 
not model glycolytic oscillations in yeast. Table XXXIV shows the initial species 
concentrations from BioModel 176 that were also used in the SimBiology model. The 
best fit to BioModel 176 was achieved by adjusting the twelve variables shown in Table 
XXXIV until the SimBiology simulations matched the simulations from BioModel 176. 
BioModel 176 had simulations available for all of the glycolysis species. The best 
fit to BioModel 176 used the values found in Table XXXIV for the enzyme 
concentrations and reaction rates. The simulations from this best fit are shown next to the 
simulations from BioModel 176 in Figure 105 and Figure 106. 
 
 
Figure 105. Simulations from (A) BioModel 176 and (B) SimBiology model for the 
species glucose-6-phosphate, fructose-6-phosphate, fructose-1,6-bisphosphate, 








Figure 106. Simulations from (A) BioModel 176 and (B) SimBiology model for the 
species intracellular glucose, glyceraldehyde-3-phosphate, 1,3-diphosphoglycerate, 2-
phosphoglycerate, and phosphoenolpyruvate. 
 
 
Table XXXIV. Initial substrate concentrations, enzyme concentrations, and reaction rates 
used to compare the SimBiology model to BioModel 176. 





GLC_ex 50000 µM Conant & Wolfe, 2007 
GLC 97.7 µM Conant & Wolfe, 2007 
G6P 2675 µM Conant & Wolfe, 2007 
F6P 625 µM Conant & Wolfe, 2007 
FBP 6221 µM Conant & Wolfe, 2007 
GAP 45.2 µM Conant & Wolfe, 2007 
DHAP 1004 µM Conant & Wolfe, 2007 
DPG 0.74 µM Conant & Wolfe, 2007 
3PG 886 µM Conant & Wolfe, 2007 
2PG 128 µM Conant & Wolfe, 2007 
PEP 63.2 µM Conant & Wolfe, 2007 
PYR 1815 µM Conant & Wolfe, 2007 
Enzyme 
Concentrations  
Used to Fit Model 
KIN 454.8 µM ----- 
PGI 60 µM ----- 
6PFK 0.79 µM ----- 
FBA 0.744 µM ----- 
TPI 0.2248 µM ----- 
GAD 307.9 µM ----- 
PGK 23.45 µM ----- 
PGM 0.3752 µM ----- 
ENO 61.1 µM ----- 
PYK 1.642 µM ----- 
Reaction Rates 
Used to Fit Model 
R0 0.001 µM/s ----- 
R27 0.0496 µM/s ----- 
A B 
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BioModel 177 - Conant 2007 Glycolysis 2C: 
 
BioModel 177 is based on the same study for S. cerevisiae as BioModel 176 
(Conant & Wolfe, 2007). The main difference between models is that BioModel 177 
includes acetyl-CoA synthesis from pyruvate. This is the only glycolysis BioModel that 
simulates acetyl-CoA. In order to fit simulations of acetyl-CoA to the BioModel, 
Reaction 28 was added to account for acetyl-CoA that is used elsewhere in the cell. 
Reaction 28 uses simple mass action kinetics, and the rate value was adjusted to achieve 
the best fit to the simulations from BioModel 177. 
Initial substrate concentrations in the SimBiology model were set equal to initial 
concentrations used in BioModel 177. These values are shown in Table XXXV. The best 
fit to BioModel 177 was found by varying the values for the ten glycolysis enzymes and 
the three reaction rates for Reaction 0, Reaction 27, and Reaction 28. The values that 
resulted in the best fit are shown in Table XXXV. 
Simulations for each glycolysis substrate and acetyl-CoA were compared between 
the SimBiology model and BioModel 177. The simulation values of acetyl-CoA, 
pyruvate, and fructose-1,6-bisphosphate were very similar between the models as shown 
in Figure 107. Comparable values were seen between the models for the rest of the 
species as shown in Figure 108, Figure 109, and Figure 110. 
 
Target Values in Glycolysis for the SimBiology Model: 
 
Comparisons with the seven glycolysis BioModels resulted in a distribution of 
enzyme concentrations, reaction rates, and initial species concentrations that could be 
used in the final SimBiology model. Figure 111 shows box plots representing the range 
of values used for the initial species concentrations in glycolysis. Ten outliers out of 84 
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values were identified in these box plots. Outliers were removed and then an average 
value was calculated for each species. Table XXXVI shows the resulting averages that 
were used in the final SimBiology model for initial species concentrations. 
The distribution of rate values for Reaction 0 and Reaction 27 are shown by the 
box plots in Figure 112. One outlier out of 14 values was identified and removed before 
average values were calculated. Table XXXVI shows the resulting averages that were 
used as reaction rates in the final SimBiology model. 
 
Table XXXV. Initial substrate concentrations, enzyme concentrations, and reaction rates 
used to compare the SimBiology model to BioModel 177. 





GLC_ex 50000 µM Conant & Wolfe, 2007 
GLC 97.7 µM Conant & Wolfe, 2007 
G6P 2675 µM Conant & Wolfe, 2007 
F6P 625 µM Conant & Wolfe, 2007 
FBP 6221 µM Conant & Wolfe, 2007 
GAP 45.2 µM Conant & Wolfe, 2007 
DHAP 1004 µM Conant & Wolfe, 2007 
DPG 0.74 µM Conant & Wolfe, 2007 
3PG 886 µM Conant & Wolfe, 2007 
2PG 128 µM Conant & Wolfe, 2007 
PEP 63.2 µM Conant & Wolfe, 2007 
PYR 1815 µM Conant & Wolfe, 2007 
Enzyme 
Concentrations  
Used to Fit Model 
KIN 90.0 µM ----- 
PGI 31.8 µM ----- 
6PFK 0.69 µM ----- 
FBA 415.9 µM ----- 
TPI 0.161 µM ----- 
GAD 159.0 µM ----- 
PGK 58.0 µM ----- 
PGM 0.2298 µM ----- 
ENO 50.01 µM ----- 
PYK 1.12 µM ----- 
Reaction Rates 
Used to Fit Model 
R0 0.0005 µM/s ----- 
R27 0.0264 µM/s ----- 
R28 0.00521 µM/s ----- 
 
 




Figure 107. Simulations from (A) BioModel 177 and (B) SimBiology model for the 




Figure 108. Simulations from (A) BioModel 177 and (B) SimBiology model for the 
species intracellular glucose, glucose-6-phosphate, fructose-6-phosphate, 




 Figure 109. Simulations from (A) BioModel 177 and (B) SimBiology model for the 














Figure 111. Box plots showing the distribution of initial values for (A) glucose, 
glyceraldehyde-3-phosphate, 1,3-diphosphateglycerate, 2-phosphoglycerate, 
phosphoenolpyruvate, (B) glucose-6-phosphate, fructose-1,6-bisphophate, 
dihydroxyacetone phosphate, pyruvate, (C) fructose 6-phosphate, and 3-phosphoglycerate 









Figure 112. Box plots showing the distribution of rates for (A) Reaction 0 and (B) 
Reaction 27 used to fit the seven glycolysis BioModels. One outlier out of 14 values was 
identified from these box plots. 
 
 
Table XXXVI. Initial substrate concentrations, target enzyme concentrations, and 
reaction rates used for the final model based on the seven glycolysis BioModels. Values 
are averages of the seven BioModels once outliers have been removed. 





GLC 70.9 µM 
G6P 2619 µM 
F6P 594 µM 
FBP 5763 µM 
GAP 43.9 µM 
DHAP 2214 µM 
DPG 7.0 µM 
3PG 890 µM 
2PG 126 µM 
PEP 59.9 µM 
PYR 2012 µM 
Target Enzyme 
Concentrations 
for Final Model 
KIN 288 µM 
PGI 46 µM 
6PFK 0.72 µM 
FBA 538 µM 
TPI 0.26 µM 
GAD 252 µM 
PGK 32 µM 
PGM 0.82 µM 
ENO 169 µM 
PYK 1.47 µM 
Reaction Rates 
in Final Model 
R0 0.006 µM 
R27 0.0248 µM 
R28 0.00521 µM 
 
A B 
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Distributions of the glycolysis enzyme values are shown in the box plots in Figure 
113. Seven outliers out of 70 values were identified in the box plots. The outliers were 
removed, and then average enzyme values were calculated. The average enzyme values 
are shown in Table XXXVI and were used as target values in the model. 
 
 
Figure 113. Box plots showing the distribution of values for the enzymes (A) kinase, 
fructose-bisphosphate aldolase, glyceraldehyde-3-phosphate dehydrogenase, enolase (B) 
6-phosphofructokinase, triose phosphate isomerase, phosphoglycerate mutase, pyruvate 
kinase (C) phosphoglucose isomerase, and phosphoglycerate kinase used to fit the seven 
glycolysis BioModels. Seven outliers out of 70 values were identified in these box plots. 
 
Due to the presence of the transcriptional network, enzyme concentrations were 
not held constant in the final model. Initial enzyme concentrations in the final model 
were set equal to the values in Table XXXVI. Enzyme concentrations during the 
A B 
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simulation are combination of the synthesis and degradation of the enzymes. Each 
enzyme was monitored during simulations, and then promoter activity and enzyme 
degradation rates were adjusted in order to achieve enzyme concentrations close to the 
target values shown in Table XXXVI. 
  
TCA Cycle BioModels: 
The BioModels 222 and 232 were used to validate the TCA cycle in the predictive 
model. The online simulator in the BioModels database was used to create simulations of 
the substrates in the TCA cycle. Values in the SimBiology model were adjusted to mimic 
the simulations of each BioModel. 
The BioModels 222 and 232 do not account for glycolysis, acetyl-CoA synthesis, 
or PHB synthesis. In the SimBiology model, these four pathways were shut off by 
inactivating the forward and reverse directions of Reaction 1, Reaction 13, Reaction 14, 
and Reaction 26. The concentration of each enzyme was held constant in order to 
inactivate the transcriptional network portion of the model. The concentration of acetyl-
CoA was held constant in both BioModels and in the SimBiology model. The 
concentrations of CoA, ATP, ADP, NAD
+
, and NADH were also held constant during 
simulation. Initial concentrations of substrates in the TCA cycle were changed to match 
the initial values used in each BioModel. The values for TCA cycle enzyme 
concentrations were adjusted until the SimBiology simulations matched the simulations 
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BioModel 222 - Singh 2006 TCA Cycle: 
BioModel 222 is the only BioModel that simulates the TCA cycle in E. coli 
(Singh & Ghosh, 2006). BioModel 222 includes the glyoxylate bypass in the TCA cycle 
and has simulations available for ten species in the TCA cycle. BioModel 222 held 
acetyl-CoA constant during simulations, so acetyl-CoA was also held constant in the 
SimBiology model. Initial species concentrations in the SimBiology model were set equal 
to the values used in BioModel 222 that are shown in Table XXXVII. A best fit was 
determined by adjusting the TCA cycle enzyme concentrations and comparing 
simulations. 
 
Table XXXVII. Initial substrate concentrations and enzyme concentrations used to 
compare the SimBiology model to BioModel 222. 




Ac-CoA 500 µM Singh & Ghosh, 2006 
OAA 4 µM Singh & Ghosh, 2006 
CIT 3000 µM Singh & Ghosh, 2006 
ISO 18 µM Singh & Ghosh, 2006 
2-OXO 200 µM Singh & Ghosh, 2006 
SCA 40 µM Singh & Ghosh, 2006 
SUC 600 µM Singh & Ghosh, 2006 
FUMA 300 µM Singh & Ghosh, 2006 
MAL 1800 µM Singh & Ghosh, 2006 
GLY 4000 µM Singh & Ghosh, 2006 
Enzyme 
Concentrations 
Used to Fit Model 
CS 28.0 µM ----- 
CHL 1800 µM ----- 
ICHL 10.0 µM ----- 
ICDH 0.3 µM ----- 
OGDH 25770 µM ----- 
SCS 7.0E-6 µM ----- 
SDH 6.5 µM ----- 
FUM 0.1165 µM ----- 
MDH 3.7 µM ----- 
IL 0.1 µM ----- 
MS 10 µM ----- 
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Simulations for each TCA cycle species closely matched the simulations from 
BioModel 222 when the enzyme concentrations in Table XXXVII were used. Figure 114 
visually compares the values for acetyl-CoA, malate, fumarate, succinyl-CoA, and 
succinate between BioModel 222 and the SimBiology model. Figure 115 illustrates the 
closely matched values for oxaloacetate, 2-oxoglutarate, and isocitrate between the two 
models. Figure 116 shows the comparison between the last two species: citrate and 
glyoxylate. 
 
Figure 114. Simulations from (A) BioModel 222 and (B) SimBiology model for the 
species acetyl-CoA, succinyl-CoA, succinate, fumarate, and malate. 
 
 
Figure 115. Simulations from (A) BioModel 222 and (B) SimBiology model for the 








Figure 116. Simulations from (A) BioModel 222 and (B) SimBiology model for the 
species citrate and glyoxylate. 
 
BioModel 232 - Nazaret 2009 TCA Cycle: 
 
BioModel 232 was the only other BioModel found for the TCA cycle. The model 
simulates the TCA cycle in Homo sapiens (Nazaret et al, 2009). This BioModel was not 
the most desirable to use because it does not model the TCA cycle in a microorganism 
and it only simulates four of the TCA cycle species. BioModel 232 also does not include 
the glyoxylate bypass. However, since only two BioModels simulate the TCA cycle, it 
was decided to try and fit the SimBiology model to BioModel 232. Table XXXVIII 
shows the initial species concentrations used in BioModel 232 that were also used in the 
SimBiology model. BioModel 232 did not have initial values for five of the TCA cycle 
species, so initial values from BioModel 222 were used. 
The TCA cycle enzyme concentrations were varied in the SimBiology model in 
order to find the best fit to BioModel 232. The values of isocitrate lyase and malate 
synthase were automatically set to zero since BioModel 232 did not include the 
glyoxylate bypass. However, only three of the enzymes could be confidently adjusted and 
fit to BioModel 232 since the model only had simulations available for acetyl-CoA, 
A B 
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oxaloacetate, citrate, and 2-oxoglutarate. Table XXXVIII shows the values used to fit the 
SimBiology model to BioModel 232. The values for citrate synthase, citrate hydro-lyase, 
and 2-oxoglutarate dehydrogenase were the key to matching the simulations of the four 
TCA cycle species between models. Figure 117 illustrates the fit between the SimBiology 
model and BioModel 232 based on four of the TCA cycle species. 
 
Table XXXVIII. Initial substrate concentrations and enzyme concentrations used to 
compare the SimBiology model to BioModel 232. 





Ac-CoA 63 µM Nazaret et al, 2009 
OAA 5 µM Nazaret et al, 2009 
CIT 440 µM Nazaret et al, 2009 
ISO 18 µM Singh & Ghosh, 2006 
2-OXO 225 µM Nazaret et al, 2009 
SCA 40 µM Singh & Ghosh, 2006 
SUC 600 µM Singh & Ghosh, 2006 
FUMA 300 µM Singh & Ghosh, 2006 
MAL 1800 µM Singh & Ghosh, 2006 
Enzyme 
Concentrations 
Used to Fit 
Model 
CS 18.0 µM ----- 
CHL 44.5 µM ----- 
ICHL 1.0 µM ----- 
ICDH 1.0 µM ----- 
OGDH 1770.4 µM ----- 
SCS 50.0 µM ----- 
SDH 50.0 µM ----- 
FUM 50.0 µM ----- 
MDH 50.0 µM ----- 
IL 0 µM ----- 
MS 0 µM ----- 
 
Target Values in the TCA Cycle for the SimBiology Model: 
 
For the final SimBiology model, it was decided to use the initial species 
concentrations in Table XXXVII that were used in BioModel 222. These values were 
chosen because BioModel 222 was specifically for E. coli and had values for each TCA 
cycle species. Initial enzyme concentrations were set to the values in Table XXXVII. In 
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the final model, promoter activity and enzyme degradation rates were adjusted to 
simulate enzyme concentrations consistent with the target values in Table XXXVII. 
 
 
Figure 117. Simulations from (A) BioModel 232 and (B) SimBiology model for the 
species acetyl-CoA, 2-oxoglutarate, citrate, and oxaloacetate. 
 
 
Comparing Model with Experimental Data 
No BioModels were available for the synthesis of PHB. The PHB synthesis 
pathway in the model was validated using experimental data for PHB production. Table 
XXXIX contains preliminary experimental PHB production data for two strains of E. 
coli. Each strain contains the genes for the PHB synthesis pathway, but they are carried in 
different plasmids. The SimBiology model was built specifically for E. coli carrying the 
pBHR68 plasmid. The data for the 4MHT plasmid was included to demonstrate that the 
predictive model is capable of being fitted to a specific strain of bacteria. 
The enzymes in the PHB synthesis pathway (PhaA, PhaB, and PhaC) were held 
constant in order to fit the model to the data. Different enzyme concentrations were tried 
until the simulated PHB closely matched the PHB production data. Figure 118 shows the 
A B 
  126 
 
 
simulations that best fit the PHB production data for the two strains. Table XL shows the 
enzyme concentrations used to achieve these two fits. 
 
Table XXXIX. Experimental data for PHB production in E. coli strains containing 4MHT 
or pBHR68 plasmids. 















*Plasmid 4MHT consists of the pBHR68 genes, the phasin 
gene phaP1, and the membrane protein gene hlyA. 
 
 
   
Figure 118. Simulated PHB fit to the PHB production data from the E. coli strains with 
(A) the 4MHT plasmid and (B) the pBHR68 plasmid. 
 
 
In the final SimBiology model, the enzyme values were not held constant. 
Promoter activity and enzyme degradation rates were adjusted to generate the desired 
enzyme concentrations. The concentrations in Table XL for the pBHR68 data were the 
target values used since the model was created for the pBHR68 strain. Experimental data 
from metabolic profiling can be used in the same way as the PHB production data. A 
A B 
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better predictive model for a specific microorganism can be created by fitting the model 
to more experimental data from that specific strain. A tutorial on how to download and 
use the final model is available in Appendix D. 
 
Table XL. Enzyme concentrations used to fit the model to experimental PHB production 
data. 







pBHR68 PhaB 0.41 
 PhaC 0.5 
*Plasmid 4MHT consists of the pBHR68 genes, the phasin 
gene phaP1, and the membrane protein gene hlyA. 
 
Model Optimization and Results 
The final SimBiology model was used to identify target genes and promoters for 
genetic engineering. In the model, the value Km is a quantitative measure of the binding 
affinity an enzyme has with its substrate. Lower values of Km represent higher substrate 
affinity while higher values of Km represent lower substrate affinity. An enzyme’s 
substrate affinity is dependent upon the amino acids that interact with the substrate in the 
enzyme’s active site. These amino acids can be identified in the gene and then site-
directed mutagenesis can be used to change one or more of these amino acids. Changing 
the amino acids of the active site can increase or decrease the enzyme’s substrate affinity 
depending upon the new amino acids used. However, it is easier to make an enzyme less 
effective at binding a substrate than trying to make it more effective. 
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In the final SimBiology model, Km values for each enzyme were adjusted and 
simulations were conducted to determine if the changes resulted in an increase in PHB 
production. Adjusting the Km values resulted in no visible increase in PHB production for 
16 enzymes, a slight increase in PHB production for 5 enzymes, and a large increase in 
PHB production for 9 enzymes. 
The transcriptional network portion of the model was also adjusted to optimize 
the model for increased PHB production. Most promoters, transcription factors, and 
ligands were not adjusted for optimization because of their wide use in metabolic 
pathways not included in the model. Adjustments were conducted on the transcriptional 
network directly associated with the pBHR68 plasmid that encodes the genes of the PHB 
synthesis pathway. 
 
Adjusting Enzyme Substrate Affinity: 
The Km values for each of the 30 enzymes in this model were increased up to five 
times or decreased down to a fifth of the original value. These values were used to 
standardize comparisons of increased PHB production between enzymes. This is roughly 
the same as making the enzyme active site five times less effective at binding the 
substrate or five times more effective at binding the substrate. The direction of 
adjustment that resulted in an increase in PHB production was the simulation kept for 
comparison. Simulations were compared between enzymes to determine which 
adjustments resulted in the greatest increase in PHB production. 
 
PHB Synthesis Enzymes: 
 
Decreasing the Km value for β-ketothiolase (PhaA) increased the PHB production 
as shown in Figure 119. Decreasing the Km by one-fifth resulted in a 35.3% increase in 
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PHB production. If β-ketothiolase has a better binding affinity then it results in higher 
synthesis of PHB. 
The enzyme acetoacetyl-CoA reductase (PhaB) has a Km value for the substrate 
acetoacetyl-CoA and the substrate NADPH. A five-fold decrease in the Km value for 
acetoacetyl-CoA resulted in a 1.0% increase in the rate of PHB production, and 
decreasing the Km for NADPH by a fifth resulted in a 7.6% increase in the rate of PHB 
production as seen Figure 120. By decreasing both Km values, an 8.6% increase in the 
rate of production was observed as seen in Figure 121. 
 
 
Figure 119. PHB production levels from adjusting PhaA’s Km for acetyl-CoA. 
 
   
  
Figure 120. PHB production levels from adjusting PhaB’s Km for (A) acetoacetyl-CoA 
and (B) NADPH. 
A B 
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The enzyme PHB synthase (PhaC) has a Km value for the substrate 3-
hydroxybutyryl-CoA. Adjusting the Km value resulted in no visible change in the 
production of PHB. Figure 122 shows the lack of change in PHB production when 
compared to the original simulation. Out of the three PHB synthesis enzymes, adjusting 
β-ketothiolase resulted in the largest increase in total PHB production. 
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TCA Cycle Enzymes: 
 
Citrate synthase has a Km value for oxaloacetate and acetyl-CoA. Increasing the 
Km for oxaloacetate by five fold resulted in 30.3% increase in PHB production as seen in 
Figure 123. Multiplying the Km for acetyl-CoA by five resulted in an 87.7% increase in 
PHB production as seen in Figure 123. A large 113.7% increase in PHB production was 




Figure 123. PHB production levels from adjusting citrate synthase’s Km for (A) 




Figure 124. PHB production levels from adjusting citrate synthase’s Km for oxaloacetate 
and acetyl-CoA. 
A B 
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Adjusting the Km value for citrate hydro-lyase resulted in no visible increase in 
the production of PHB. Increasing the Km value for the enzyme isocitrate hydro-lyase 
resulted in a very slight increase in PHB production. The simulations for these two 
enzymes can be found in Appendix C. 
Adjusting the substrate affinity for isocitrate dehydrogenase yielded a visible 
change in the amount of PHB synthesized. Decreasing the enzyme’s Km for isocitrate by 
one fifth resulted in a 7.8% increase in PHB production as shown in Figure 125. Altering 
the Km for the enzyme 2-oxoglutarate dehydrogenase had no visible effect upon the 
synthesis of PHB. The simulation from adjusting the Km of 2-oxoglutarate dehydrogenase 
is found in Appendix C. 
 
 
Figure 125. PHB production levels from adjusting isocitrate dehydrogenase’s Km for 
isocitrate. 
 
The enzyme succinyl-CoA synthetase catalyzed the only reaction not modeled 
using a kinetic mechanism. The reaction rate was adjusted in place of a Km value. 
Increasing the rate of reaction for succinyl-CoA synthetase resulted in a barely noticeable 
increase in PHB production. This simulation is included in Appendix C. 
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Adjusting the Km values for the enzymes succinate dehydrogenase, fumarase, and 
malate dehydrogenase resulted in no visible increase in PHB production. The simulations 
for these enzymes are included in Appendix C. 
 
Glyoxylate Bypass Enzymes: 
 
Increasing the Km for the enzyme isocitrate lyase resulted in an 8.6% increase in 
the synthesis of PHB as shown in Figure 126. For the enzyme malate synthase, no change 
in PHB production was observed from adjusting the Km for glyoxylate and a very slight 
increase in PHB production was observed from increasing the Km for acetyl-CoA. The 
two simulations for malate synthase are included in Appendix C. 
 
 




Altering the Km values for the enzymes kinase, phosphoglucose isomerase, and 6-
phosphofructokinase resulted in no visible increase in the production of PHB. The 
simulations for these enzymes are found in Appendix C. Increasing the Km by five fold 
for the enzyme fructose-bisphosphate aldolase resulted in a 22.5% increase in PHB 
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production as seen in Figure 127. For the enzyme triose phosphate isomerase, multiplying 
the Km value by five resulted in a 7.1% increase in PHB synthesis as seen in Figure 128. 
 
 




Figure 128. PHB production levels from adjusting triose phosphate isomerase’s Km for 
dihydroxyacetone phosphate. 
 
The enzyme glyceraldehyde-3-phosphate dehydrogenase binds three substrates so 
it has Km values for glyceraldehyde-3-phosphate, NAD
+
, and inorganic phosphate. 
Adjusting the Km for glyceraldehyde-3-phosphate resulted in no visible increase in PHB 
production and the simulation is included in Appendix C. An 8.6% increase in PHB 
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synthesis was observed from increasing Km by five-fold for inorganic phosphate as 
shown in Figure 129. Increasing the Km for NAD
+
 by five-fold resulted in a 37.6% 
increase in the synthesis of PHB as seen in Figure 129. A total increase of 72.8% in PHB 
production was observed by increasing all three Km values by five fold as shown in 
Figure 130. 
 
   
Figure 129. PHB production levels from adjusting glyceraldehyde-3-phosphate 
dehydrogenase’s Km for (A) NAD
+




Figure 130. PHB production levels from adjusting glyceraldehyde-3-phosphate 
dehydrogenase’s Km for NAD
+
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No visible increase in PHB production was observed by altering the Km values for 
the enzymes phosphoglycerate kinase, phosphoglycerate mutase, and enolase. The 
enzyme pyruvate kinase has a Km for phosphoenolpyruvate and ADP. Increasing or 
decreasing the Km for phosphoenolpyruvate resulted in no visible change in the 
production of PHB. A very slight increase in PHB production was observed by increasing 
the Km for ADP. The simulations for these four enzymes are available in Appendix C. 
 
Acetyl-CoA Synthesis Enzymes: 
 
The only enzyme in the acetyl-CoA synthesis pathway is the multienzyme 
complex pyruvate dehydrogenase. Figure 131 shows that an increase in PHB production 
is the result of decreasing the Km value for the substrate pyruvate. Decreasing Km by one-
fifth resulted in a 26.0% increase in the synthesis of PHB. 
 
 





Large increases in PHB production were observed by adjusting the Km values for 
β-ketothiolase, acetoacetyl-CoA reductase, citrate synthase, isocitrate dehydrogenase, 
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isocitrate lyase, fructose-bisphosphate aldolase, triose phosphate isomerase, 
glyceraldehyde-3-phosphate dehydrogenase, and pyruvate dehydrogenase. The enzyme 
acetoacetyl-CoA reductase was the only enzyme where changes in Km increased the rate 
of PHB production. The largest percent increase (113.7%) came from adjusting the Km 
values for citrate synthase, and the second largest increase (72.8%) came from changing 
the Km values for glyceraldehyde-3-phosphate dehydrogenase as seen in Table XLI. 
Altering Km values resulted in a slight increase in PHB production for the 
enzymes isocitrate hydro-lyase, succinyl-CoA synthetase, malate synthase, 
phosphoglycerate mutase, and pyruvate kinase. The adjustment of Km values caused no 
increase in PHB production for the enzymes PHB synthase, citrate hydro-lyase, 2-
oxoglutarate dehydrogenase, succinate dehydrogenase, fumarate, malate dehydrogenase, 
kinase, phosphoglucose isomerase, 6-phosphofructokinase, phosphoglycerate kinase, 
enolase, glucose-1-phosphatase, fructose-1,6-bisphosphatase, phosphoenolpyruvate 
carboxykinase, and phosphoenolpyruvate  synthetase.  
 
Table XLI. Km adjustments leading to increased PHB production. Percent increase is 
from increasing or decreasing Km by five-fold. 
Enzyme Km, A Km, B Km, C % Increase 
β-ketothiolase ↓ NA NA 35.3 
Acetoacetyl-CoA reductase ↓ ↓ NA 8.6* 
Citrate synthase ↑ ↑ NA 113.7 
Isocitrate dehydrogenase ↓ NA NA 7.8 
Isocitrate lyase ↑ NA NA 8.6 
Fructose-bisphosphate aldolase ↑ NA NA 22.5 
Triose phosphate isomerase ↑ NA NA 7.1 
Glyceraldehyde-3-phosphate dehydrogenase ↑ ↑ ↑ 72.8 
Pyruvate dehydrogenase ↓ NA NA 26.0 
*Increase in rate 
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Adjusting Ligand Concentration: 
The only ligand adjusted for optimization of PHB production was IPTG. The 
ligand IPTG binds to the LacI repressor and prevents it from repressing transcription of 
the PHB synthesis genes. Concentrations of other ligands and transcription factors were 
not tested for optimization because they are widely used in metabolic pathways so the 
model cannot account for all of the effects that such changes would have on the cell. No 
significant increase in PHB production was observed from increasing or decreasing the 
concentration of IPTG as shown in Figure 132. 
 
 
Figure 132. PHB production levels from adjusting concentrations of IPTG. 
 
Adjusting Promoter Activity: 
The only promoter tested for model optimization was the lac promoter in the 
pBHR68 plasmid that regulates transcription of the PHB synthesis genes. It is easier to 
genetically engineer the plasmid than to genetically engineer promoters in the genome. 
Also, promoters in the genome often regulate the transcription of multiple genes. This 
model only accounts for a small number of genes, so it cannot accurately predict the 
effect of altering a promoter in the genome.  
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The lac promoter that regulates the PHB genes was adjusted to increase PHB 
production because all the genes in the pBHR68 plasmid are accounted for in the model. 
Multiplying the lac promoter activity (β) by a factor of five resulted in an 8.5% increase 
in PHB production as seen in Figure 133. Also, maximum PHB production was reached 
by 12 hours compared to the 43 hours observed at normal promoter activity. A factor of 
five was used to standardize comparison with the increases observed from adjusting Km 
values for the enzymes. 
 
 




An optimized model for PHB production was created by increasing promoter 
activity by five fold for the lac promoter and by increasing all Km values by five fold for 
citrate synthase and glyceraldehyde-3-phosphate dehydrogenase. This optimized model 
resulted in a 226.8% increase in PHB production achieved by 29 hours compared to 43 
hours. Figure 134 shows the comparison between the optimized model and the normal 
model. Altering the enzymes contributed mostly to the increase in total PHB production, 
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while altering the promoter activity contributed mostly to the increase in the rate of PHB 
production as illustrated by Figure 134. 
 
 
Figure 134. Simulations showing the comparisons between PHB production levels from 
the unaltered model; PHB production levels from increasing Km values for citrate 
synthase and glyceraldehyde-3-phosphate dehydrogenase; PHB production levels from 
increasing the pBHR68 lac promoter activity (β); and PHB production levels from 
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DISCUSSION AND FUTURE WORK 
Discussion 
The predictive model identified nine enzymes as potential targets for genetic 
engineering in order to optimize the production of PHB. Four of the enzymes required 
decreasing Km in order to increase PHB production. Lowering Km values is equivalent to 
increasing an enzyme’s substrate affinity. Engineering an enzyme to have a higher 
substrate affinity is a difficult task because enzymes have evolved to be efficient at 
binding their substrates. It is easier to make an enzyme less effective at binding its 
substrate. Increasing the Km values of five enzymes led to an increase in PHB production. 
The active sites of these five enzymes could be engineered to be less effective at binding 
their substrates. Therefore, the nine potential targets for genetic engineering was 
narrowed down to five enzymes. 
Out of the five enzymes, altering the Km for citrate synthase resulted in the largest 
increase in PHB production. Due to the 113.7% increase observed by increasing Km by 
five fold, citrate synthase is the first target gene for engineering. The two active sites in 
citrate synthase could be genetically engineered to be less effective at binding the 
substrates oxaloacetate and acetyl-CoA, and the result should enhance PHB production. 
Out of the five enzymes identified as potential targets, increasing the Km of 
glyceraldehyde-3-phosphate dehydrogenase caused the second largest increase observed 
in PHB production. Glyceraldehyde-3-phosphate dehydrogenase is the second target gene 
for engineering because of the 72.8% increase in PHB synthesis that resulted from 
increasing the Km values by five fold. The three active sites for glyceraldehyde-3-
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phosphate, NAD+, and inorganic phosphate could be genetically engineered to be less 
effective at binding the substrates, and the result should increase PHB production. 
The lac promoter in the pBHR68 plasmid was the third target identified for 
genetic engineering. Increasing the lac promoter activity by five times resulted in an 
8.5% increase in total PHB production and a 275% increase in the rate of PHB 
production. Genetically engineering the lac promoter in the pBHR68 plasmid to have 
greater activity should result in a significant increase in the rate of PHB production. The 
only other adjustment that resulted in an increase in the rate of PHB production was 
decreasing the Km by a fifth for the enzyme acetoacetyl-CoA reductase. However, this 
adjustment only resulted in an 8.6% increase in the rate of PHB production. Therefore, 
the lac promoter in the pBHR68 plasmid was chosen as the third target for genetic 
engineering. 
The simulation that made adjustments for all three targets resulted in a 226.8% 
increase in maximum PHB production and a 275% increase in the rate of PHB 
production. Genetically engineering a strain of E. coli that can produce more PHB in a 
shorter amount of time will help make commercial PHB production more cost effective. 
An optimized strain should be achieved by altering the genes for citrate synthase (gltA) 
and glyceraldehyde-3-phosphate dehydrogenase (gapA), and by modifying the lac 
promoter in the pBHR68 plasmid. 
Instead of genetically engineering citrate synthase and glyceraldehyde-3-
phosphate dehydrogenase to be less effective, substrate analogs could be used as 
competitive inhibitors for the enzymes. For citrate synthase, the compound 
carboxymethyl-CoA acts as an inhibitor of the transition state with a high binding 
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affinity. Theoretically, carboxymethyl-CoA could be added to the bioreactor to inhibit 
citrate synthase. For glyceraldehyde-3-phosphate dehydrogenase, adenosine analogs can 
be used as tight-binding inhibitors of the NAD
+
 active site. Adding an adenosine analog 
to the bioreactor should slow down the enzyme glyceraldehyde-3-phosphate 
dehydrogenase.  
One major disadvantage of adding a compound to the bioreactor is that the 
compound could affect more than just the target enzyme. Carboxymethyl-CoA could 
inhibit other reactions that use acetyl-CoA. Adenosine analogs could inhibit other 
reactions that use NAD
+
. Adding compounds to the bioreactor also increases production 
cost. Due to the cost and potential side effects of adding substrate analogs to the reactor, 
it was decided to focus first on genetically engineering the enzymes to be less effective. 
Flux balance analysis (FBA) has widely been used in genome-scale metabolic 
models. However, a model based on FBA would not have been able to predict that 
lowering the substrate affinity of citrate synthase or glyceraldehyde-3-phosphate 
dehydrogenase would increase PHB production. FBA is limited to predicting how the 
addition or deletion of gene affects a product’s flux. Deletion of citrate synthase or 
glyceraldehyde-3-phosphate dehydrogenase would be undesirable because they are both 
part of key energy pathways in the cell. Also, FBA would not have been able to 
quantitatively predict how adjusting promoter activity would impact PHB production 
because FBA does not account for a dynamic transcriptional network. 
Certain strains of PHB producing bacteria have been genetically engineered to 
secrete the produced PHB. Secreting PHB into the growth media can significantly reduce 
the cost of downstream processing. The secretion pathway could be added to the model to 
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predict how to optimize a PHB secreting strain of bacteria for greater PHB production. 
Another way to reduce cost of PHB production is to use a waste material as the initial 
substrate. Whey is a waste product from cheese production that contains lactose. Lactose 
could be used instead of glucose in the growth medium. The model could be adjusted to 
account for the catabolism of lactose instead of glucose. 
The design process used to make a predictive model for PHB production can be 
used to develop predictive models for other bioproducts. Useful bioproducts such as 
biofuels, biomaterials, and biopharmaceuticals are continually being developed, but often 
many years of research are required before commercial production becomes cost-
effective. Predictive models can be used to develop optimized strains of bacteria for 
production of specific bioproducts. Predictive models should help reduce time and cost 
needed to get useful bioproducts out on the market. 
 
Future Work 
Metabolic profiling can be used to more precisely fit a predictive model to a 
specific strain of E. coli. Due to the lack of a functioning mass spectrometer, this 
predictive model was not fitted to metabolic profiling data. This model is not as accurate 
as it could be if it was fitted to real time data from the specific strain of E. coli. Further 
work should be done to obtain metabolic profiling data to use in the model. 
After the model has been fitted to metabolic profiling data, the model should be 
optimized to verify that altering the effectiveness of citrate synthase, glyceraldehyde-3-
phosphate dehydrogenase, and the lac promoter in the pBHR68 plasmid will optimize 
PHB production.  
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After the target genes have been verified, they should be genetically engineered to 
mimic the optimized model. The amino acids in the active sites of citrate synthase and 
glyceraldehyde-3-phosphate dehydrogenase should be identified. One or more of the 
amino acids should be exchanged with a less effective amino acid through site-directed 
mutagenesis. This genetic engineering should result in enzymes that are less effective at 
binding their substrates. The lac promoter in the pBHR68 plasmid should be altered to 
more closely match the consensus sequence that binds RNA polymerase. This genetic 
engineering should stabilize the RNA binding and increase the activity of the lac 
promoter in the pBHR68 plasmid. 
Once the strain of E. coli has been genetically engineered for optimized PHB 
production, metabolic profiling should be conducted again. The predictive model should 
then be fit to the new metabolic profiling data. By comparing the old model with the new 
data, the accuracy of the first predictive model can be determined. The new predictive 
model can then be optimized to identify new targets for genetic engineering. This 
iterative process should be repeated until a fully optimized strain of E. coli for PHB 
production has been genetically engineered. 
The PHB predictive model designed in this project is limited to five metabolic 
pathways and accounts for only a portion of the transcriptional network. These 
limitations only allow the PHB predictive model to predict outcomes from modifying 30 
genes, one promoter, and one ligand. However, in the future the data needed to build a 
genome-scale kinetic model will become available (Jamshidi & Palsson, 2008). A 
genome-scale kinetic model would account for all the metabolic pathways and would 
include a full, dynamic transcriptional network. Such a model would be able to predict 
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the outcomes of modifying any gene, promoter, transcription factor, or ligand. A genome-
scale kinetic model would be a valuable tool in genetically engineering optimized 
organisms for the production of bioproducts.  
The PHB predictive model developed in this project is a step towards one day 
realizing a genome-scale kinetic model as shown in Table XLII. Although the data 
needed to build a genome-scale kinetic model is not yet available, progress comes from 
implementing ideas with the tools that exist today. Engineers need to build working 
models with the data and technology currently available, and then the models can be 
improved as new data and technologies are discovered. 
 
Table XLII. Comparisons between the current PHB predictive model and a future 
genome-scale kinetic model. 
 PHB Predictive Model Genome-Scale Model 
Metabolic Pathways: 5 All 
Transcriptional Network: Partial, dynamic Full, dynamic 
Predict Outcomes from Modifying: 30 genes 
1 promoter 
1 ligand 




Any transcription factor 
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HPLC-MS Analytical Methods  
Metabolic profiling samples can be analyzed for concentration of metabolites 
using high performance liquid chromatography coupled with mass spectrometry (HPLC-
MS). Standards should be used to identify and analyze concentrations of glucose, 
pyruvate, citrate, 2-oxoglutarate, succinate, fumarate, malate, oxaloacetate, and beta-
hydroxybutyrate. Dilutions of the standards should be used to create a standard curve for 
each compound. 
Mass spectrometric analysis can be conducted on an Agilient 6130 single 
quadropole mass spectrometer. High performance liquid chromatography can be 
performed on an Agilent 1200 Series HPLC. Solvent A should be an aqueous buffer, and 
Solvent B should be acetonitrile. Two methods could be used to separate desired 
metabolites. Method 1 is a reversed-phase liquid chromatography utilizing a C18 column. 
Method 2 is a hydrophilic interaction liquid chromatography utilizing an aminopropyl 
column (Bajad et al, 2006). 
Concentrations of the metabolites can be analyzed for each time sample utilizing 
HPLC-MS. An independent two-sample student’s t-statistic test could then be used to 
compare the differences in concentrations of the above-mentioned metabolites between 
the strain containing the PHB producing plasmid and the control to determine if the 
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Figure 135. PHB production levels from adjusting (A) citrate hydro-lyase’s Km for 
citrate, (B) isocitrate hydro-lyase’s Km for aconitate, (C) oxoglutarate dehydrogenase’s 
Km for 2-oxoglutarate, (D) succinyl-CoA synthetase’s reaction rate, (E) succinate 









Figure 136. PHB production levels from adjusting (A) malate dehydrogenase’s Km for 
malate, (B) malate dehydrogenase’s Km for NAD
+
, (C) malate synthase’s Km for 
glyoxylate, (D) malate synthase’s Km for acetyl-CoA, (E) kinase’s Km for glucose, and 










Figure 137. PHB production levels from adjusting (A) phosphoglucose isomerase’s Km 
for glucose-6-phosphate, (B) phosphoglucose isomerase’s Km for fructose-6-phosphate, 
(C) 6-phosphofructokinase’s Km for fructose-6-phosphate, (D) 6-phosphofructokinase’s 
Km for ATP, (E) glyceraldehyde-3-phosphate dehydrogenase’s Km for glyceraldehyde-3-









Figure 138. PHB production levels from adjusting (A) phosphoglycerate kinase’s Km for 
1, 3-diphosphateglycerate, (B) phosphoglycerate kinase’s Km for ADP, (C) enolase’s Km 
for 2-phosphoglycerate, (D) pyruvate kinase’s Km for phosphoenolpyruvate, and (E) 
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 Predictive Model: http://digitalcommons.usu.edu/engineering_datasets/1/ 
 




Type “sbiodesktop” to open SimBiology 
 
Go to File, then select Open Project, then select the Predictive Model 
  
How to Open Diagram View: 
 
In the Project Explorer window pane, expand Model Session, then expand 




Editing Properties of Species  
 
Double-click on the Species block 
 
 Settings Tab 
o Here changes can be made to the initial amount of the species 
o Select whether the species is held constant, or if the amount is determined 
by a boundary condition 





Editing Properties of Reactions 
 
Double-click on the Reaction block 
 
 Settings 
o Here changes can be made to the kinetic law and parameters 
o Reaction rate expression can be edited by clicking on the pencil icon 
o Km values can be changed by double-clicking the Value cell for Km and 
entering a new value 










o A block is cloned or split to separate a species that participates in multiple 
reactions. 
o Although there could be multiple split/clone blocks, there is only one species. 
Changes made to any settings in the Species Properties dialog box will be 






Changing a Parameter’s Scope:  
o In the Project Explorer window pane select Parameters 
o Right-click on the desired parameter in the Scope column. Select 
“Change Parameter Scope.” This toggles the scope between the reaction 
and the overall model. A parameter must have a global scope if it is used 
in an Event or a Rule. 
 
Constant: 
o The default setting for all parameters is for them to be held constant 
throughout the entire simulation. To change the parameters value partway 
through the simulation (through use of an Event), then uncheck the 




In the Project Explorer window pane select Rules 
 
4 Types of Rules: 
1. Algebraic — Evaluated continuously during a simulation 
2. Initial Assignment — Evaluated once at the beginning of the 
simulation 
3. Repeated Assignment — Evaluated at every time-step of the 
simulation 
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4. Rate — Evaluated continuously during the simulation 
Tip:   To use a parameter in a rule, remember to set the Scope of the 
parameter to “model.” To use an algebraic or rate rule to vary the 
value of a parameter during the simulation, clear the ConstantValue 
checkbox for the parameter in the Parameters pane. Also, if using a 
rule to define a species concentration, clear the ConstantAmount 




In the Project Explorer window pane select Events 
 
Events are used to describe sudden changes in model behavior. An event can 
specify discrete transitions in model component values that occur when a user-
specified condition become true. 
 
Uses:   
To activate or deactivate certain species (activator or inhibitor species), 
change parameter values, change reaction rates in response to addition or 
removal of species 
Trigger: 
The trigger can be time-dependent or time-independent 
Event Functions: 
Event functions are the results when the event is turned on by the trigger 
Active: 
The Active check box must be marked for the event to work. To simulate the 
model without the event, then clear the Active check box. 
Tip:   
To use a parameter in an event, remember to set the Scope of the parameter to 
model and to clear the ConstantValue check box for the parameter in the 












In the Project Explorer window pane expand Model Session and select 
Configuration Settings 
 
Before running a simulation, use the Configuration Settings to set the simulation 
time, solver, etc. 
 
Custom Configuration Settings: 
 
To store simulation settings for later use, type a name for the settings in 
the Enter Name edit box, and click Add to create your custom 
configuration settings. Any changes made in the Settings and Data 
Logging tabs will be saved with the project. 
 
Custom Configuration Settings Available in Predictive Model 
o CoFactor: Simulates cofactors in model 
o PHB synthesis: Simulates species in PHB synthesis pathway 
o TCA cycle: Simulates species in TCA and Glyoxylate pathways 
o Glycolysis: Simulates species in the Glycolysis pathway 
o Glucose_PHB: Simulates key species of the entire model 
 
Settings: 
o Set simulation time 
o Choose solver (Use sundial if using Events)  




In the Project Explorer window pane expand Model Session, then expand 
Model Tasks and select Simulation 
 
o In the Settings tab, select the Configuration Settings to use for the 
simulation 
o Next, select the Plots tab 
o Double click the “y” argument box to select which species to plot  
o Under Plot Behavior, select if the simulation should be a new 
figure or if it should be added to the current axes 
o Click the Run icon in the main Toolbar 
o A graph of your simulation will appear in the Figures window pane 





In the main task bar, select File, and then select Add Data, and choose From File 
 
o Select a file to download 
o Select if the first row contains header information 
o Look at the Data Preview, and if it looks good, then click Okay 
 
Plotting Multiple Simulations in a Single Figure 
 
In the Project Explorer window pane expand Model Session, then expand 
Model Tasks and select Simulation 
 
o In the Plots tab, select whether the plot should be put in a new Figure or if 
the plot should be added to the current axes. If “Add to current axes” is 
selected then the simulation will be plotted on the Figure last selected. 
This is the best way to overlay different simulations. 
 
Plotting a Dataset with a Simulation in a Single Figure 
 
In the Project Explorer window pane expand Model Session, then expand 
Model Tasks and select Simulation 
 
o In the Plots tab, select an XY Plot Type and click “Add Plot Type” 
o For the first plot (Time Plot Type), choose the Plot Behavior “New 
Figure”  
o Double-click on the “y” argument to select which species to plot 
from the simulation. 
o For the second plot (XY Plot Type), choose the Plot Behavior “Add to 
current axes”  
o Double-click on the “x” argument to select the x-variable from the 
imported dataset. Double-click on the “y” argument to select the y-
variable from the imported dataset. 
o As long as both Create Plot checkboxes are checked, a Figure will be 
created containing the simulation and the dataset 
 
 
